rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGATAGGCGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	12	842	0.006006477293803769		44	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	1	5	4	2	4	2	23	38	45	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTCGGACAGGGGTACGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGQGYGSNQPQHF	In	VDJ	8	542	0.0038664022485055145	0.0059041394335511985	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	1	3	6	23	35	47	38	53			01,02										Vb 1	CASSFGQGYGSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTCCCCGCTAGCGGGGGTGGATACGCAGTATTTTGGCCCA	CASSASPLAGVDTQYF	In	VDJ	7	498	0.0035525245751951034	0.0054248366013071895	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	6	8	2	23	36	54	44	56			01,02										Vb 1	CASSASPLAGVDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAAACAGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQTGANTGELFF	In	VDJ	6	400	0.002853433393731007	0.004357298474945534	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	2	2	3	2	23	35	45	38	47			01,02										Vb 1	CASSQTGANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAACGACAGTTGGAGACCCAGTACTTCGGGCCA	CASSERQLETQYF	In	VDJ	5	347	0.0024753534690616485	0.0037799564270152505	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	5	3	3	23	36	44	39	47			01,02										Vb 1	CASSERQLETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAGCGGGACCTACGAGCAGTACTTCGGGCCG	CASSPSGTYEQYF	In	VDJ	4	281	0.002004536959096032	0.0030610021786492375	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	3	2	1	0	23	35	-1	36	45			01,02										Vb 1	CASSPSGTYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGCTCTTTATCAGGGTTGGGCACTGAAGCTTTCTTTGGACAA	CASSVGSLSGLGTEAFF	In	VDJ	4	270	0.0019260675407684297	0.0029411764705882353	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	4	11	5	23	37	53	48	58			01,02										Vb 1	CASSVGSLSGLGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGACAGGAATAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGIGTGELFF	In	VDJ	1	101	7.204919319170792E-4	0.0011002178649237473	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	4	4	0	6	23	-1	46	39	52			01,02										Vb 1	CASSVGTGIGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAACGAGCAAGGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASNEQGTTGELFF	In	VDJ	1	92	6.562896805581316E-4	0.0010021786492374729	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	6	1	8	4	8	2	23	33	44	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASNEQGTTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPSSYNEQFF	In	VDJ	1	75	5.350187613245638E-4	8.169934640522876E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	8	0	1	0	23	35	-1	36	40			01,02			01,02							Vb 1	CASSPSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGCCTCCTTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSVEASLAKNIQYF	In	VDJ	1	58	4.13747842090996E-4	6.318082788671023E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-04	01	0	5	4	1	0	8	23	-1	42	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEASLAKNIQYF+TCRBV09-01+TCRBJ02-04	TCRBV09-01		TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTCGTGGAGGCGAGAGGAAACACCATATATTTTGGAGAG	CASSVVEARGNTIYF	In	VDJ	1	57	4.066142586066685E-4	6.209150326797386E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	1	4	6	5	23	34	45	40	50			01,02										Vb 1	CASSVVEARGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGAAGAGGGGTTCAGAGAGACCCAGTACTTCGGGCCA	CASREEGFRETQYF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	5	5	2	4	5	5	23	34	44	39	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASREEGFRETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCCCCCGAGACGTACGAGCAGTACTTCGGGCCG	CASSVAPETYEQYF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	2	7	4	7	1	23	39	49	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVAPETYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCAGGACTAGCGGGGTAAGAAATGAGCAGTTCTTCGGGCCA	CASSSRTSGVRNEQFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	7	4	5	23	35	51	39	56			01,02										Vb 1	CASSSRTSGVRNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGACCCGAACAGGGGCGGGACAGATACGCAGTATTTTGGCCCA	CASSDPNRGGTDTQYF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	3	6	4	23	36	49	42	53			01,02										Vb 1	CASSDPNRGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTGGGGCTGGGGACTGAAGCTTTCTTTGGACAA	CASSVVGLGTEAFF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	5	1	5	23	39	45	40	50			01,02										Vb 1	CASSVVGLGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCAAAGGTGGCACTGAAGCTTTCTTTGGACAA	CASSVKGGTEAFF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	2	5	4	4	3	3	23	37	43	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVKGGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGGCTGACGCCGGGGGAGCGCGTGGCTACACCTTCGGTTCG	CASRADAGGARGYTF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	7	9	6	23	34	49	43	55			01,02										Vb 1	CASRADAGGARGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTCCGGGACAGGGAGGAATGAGCAGTTCTTCGGGCCA	CASSSGTGRNEQFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	42	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	7	2	3	19	32	43	34	46														CASSSGTGRNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCAGGCTAGCTTCCTCAATGAGCAGTTCTTCGGGCCA	CASSPQASFLNEQFF	In	VDJ	8	588	0.00419454708878458	0.006405228758169935	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	6	6	5	29	42	53	48	58						01,02							Vb 16	CASSPQASFLNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCCCAGACCCAGTACTTCGGGCCA	CASSQGAQTQYF	In	VDJ	8	571	0.004073276169551012	0.00622004357298475	36	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	6	0	2	29	-1	49	45	51													Vb 16	CASSQGAQTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGAGGCGACACCGACGCCTACGAGCAGTACTTCGGGCCG	CASRGDTDAYEQYF	In	VDJ	5	319	0.002275613131500478	0.0034749455337690634	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	2	4	6	29	40	48	44	54													Vb 16	CASRGDTDAYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAAGGGAGAAGGGGCTCAAGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	205	0.001462384614287141		55	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	0	5	2	2	8	8	26	43	56	51	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGACAGGTCTATCTTCTTGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	144	0.0010272360217431626		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	4	6	2	14	28	44	54	46	68													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCTAATAGGGGGCTATGGCTACACCTTCGGTTCG	CASSQDLIGGYGYTF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	1	4	6	0	29	46	-1	52	58													Vb 16	CASSQDLIGGYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGTAGCGGGGGGGCCGTAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	71	5.064844273872537E-4		56	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	2	3	6	25	42	56	45	62													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTGAAGGACAGACCACTGAAGCTTTCTTTGGACAA	CASSEGQTTEAFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	4	4	2	29	40	50	44	52													Vb 16	CASSEGQTTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGCGACAGGAGGTCGATACAATGAGCAGTTCTTCGGGCCA	CASSATGGRYNEQFF	In	VDJ	1	52	3.709463411850309E-4	5.664488017429193E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	4	4	2	7	29	41	49	43	56													Vb 16	CASSATGGRYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCAGGGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	3.1387767331041074E-4		38	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	6	1	0	29	45	-1	46	53													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAAGGGAGAAGGGGTTCAAGATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	1.712060036238604E-4		55	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	0	5	2	1	8	7	26	43	56	51	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGCGGGGGGAGTCTACGAGCAGTACTTCGGGCCG	CASSVGAGGVYEQYF	In	VDJ	3	201	0.001433850280349831	0.0021895424836601307	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	1	3	6	3	24	36	50	42	53														CASSVGAGGVYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGCTTGATGTTAGGGGACAGGGGAATGATGGCTACACCTTCGGTTCG	CASTLDVRGQGNDGYTF	In	VDJ	1	65	4.636829264812886E-4	7.080610021786493E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	2	6	16	4	24	31	57	47	61														CASTLDVRGQGNDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTCAGGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSVQGQGAYEQYF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	2	5	0	24	36	-1	41	52														CASSVQGQGAYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGCGAGGAAGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASRARKTE*KTYGYTF	Stop	VDJ	1	59	4.2088142557532353E-4		51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	9	11	24	35	48	44	59						01,02								CASRARKTE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCATGGAGCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	3.352784237633933E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	2	1	5	2	24	36	45	41	47														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCGCCGGAGGGGGGCTCCTGTACCAAGAGACCCAGTACTTCGGGCCA	CASSSAGGGLLYQETQYF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	54	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	5	5	1	0	8	8	24	36	50	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAGGGLLYQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGGACAGGGTGTTAATGAGCAGTTCTTCGGGCCA	CASSPGQGVNEQFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	2	4	24	36	47	38	51														CASSPGQGVNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAATGAGGCCGCCGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSK*GRRGNQPQHF	Stop	VDJ	1	23	1.640724201395329E-4		48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	1	2	1	8	24	39	44	40	52														CASSK*GRRGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCGCTCCAACTGAGTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	22	1.5693883665520537E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-06	01	6	3	6	5	16	5	24	35	54	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01		TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGATACGAGACAGGGAACATTCAGTACTTCGGCGCC	CASSLGYETGNIQYF	In	VDJ	1	80	5.706866787462013E-4	8.714596949891067E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	3	7	7	0	18	34	-1	41	48														CASSLGYETGNIQYF+TCRBV07-06+TCRBJ02-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGGAGGGGGCCGGACTGAAGCTTTCTTTGGACAA	CASSFGGGRTEAFF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	5	3	3	18	32	42	35	45														CASSFGGGRTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCTATACCATTGGACCCGAGCAGTTCTTCGGGCCA	CASSSYTIGPEQFF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-01	01	4	1	7	10	11	2	18	31	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYTIGPEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCCGGCAGGGAGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	2.4254183846713557E-4		46	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	3	8	0	18	32	-1	40	46														X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGGGACAGGCGGAGGGGCAGCCCCAGCATTTTGGTGAT	CASSLGGQAEGQPQHF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	4	7	1	8	18	34	43	35	51														CASSLGGQAEGQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGAGCCCGCGTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRARVANTGELFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	6	7	0	2	8	18	30	35	32	43						01,02								CASSRARVANTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAAAGGACAGGGTGTGAACACCATATATTTTGGAGAG	CASSLKGQGVNTIYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	3	7	3	4	18	33	44	36	48														CASSLKGQGVNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATACTCCCAAGGGGATGAGCAGTTCTTCGGGCCA	CASSLYSQGDEQFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	8	8	0	18	33	-1	41	46														CASSLYSQGDEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGATTACCGCGACAGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	1.4267166968655033E-4		49	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	1	10	1	18	32	47	42	48														X+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTACTTATCCCGGACAGGGTTAGGTGAGCAATTCTTCGGGCCA	CASSYLSRTGLGEQFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	3	16	9	12	19	32	49	41	61														CASSYLSRTGLGEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCTACAGGGGGCGCATGGAGACCCAGTACTTCGGGCCA	CASSSYRGRMETQYF	In	VDJ	1	29	2.06873921045498E-4	3.159041394335512E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	0	5	3	5	19	32	44	35	49														CASSSYRGRMETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCTGTGTATCTCTGTGCTATTCTCAGGGGGGGCGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.9974033756117049E-4		40	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-05	01	11	4	1	4	6	4	19	24	37	30	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCTGTGTATCTCTGTGCCAGAAGTTTGGGTCCCCGCCAGACTAGCCGACCTTAGAGAGTTCTTCGGGCCA		Out	VDJ	1	23	1.640724201395329E-4		52	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	7	14	15	11	19	30	52	45	63						01,02								X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGGGTACCTTCGGGACCATTTTGGCAGT	CASSEGGYLRDHF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-04	01	1	0	7	19	12	2	23	39	56	51	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGGYLRDHF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTAGTCCCGGCCGCGTCCTCGGGCTATGGCTACACCTTCGGTTCG	CASSEVVPAASSGYGYTF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	4	18	0	23	39	-1	57	61						01,02								CASSEVVPAASSGYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTACGAGGGCCAGGGCGGACAGATACGCAGTATTTTGGCCCA	CASSLRGPGRTDTQYF	In	VDJ	1	69	4.922172604185987E-4	7.516339869281046E-4	48	TCRBV07	TCRBV07-04	01				TCRBJ02	TCRBJ02-03	01	2	4	3	3	7	3	22	37	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGPGRTDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCCGACAGGACCCGCGAGCAGTACTTCGGGCCG	CASSPDRTREQYF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	39	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	6	3	5	22	34	43	37	48														CASSPDRTREQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAACGGGACTAGCCGGAGATACGCAGTATTTTGGCCCA	CASSLTGLAGDTQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	45	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	7	5	2	3	22	37	48	39	51						01,02								CASSLTGLAGDTQYF+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGAGAAAAGAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	11	769	0.005485725699447861		38	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	11	2	5	1	7	26	38	42	39	49													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTGGGGACAGAGAAGAATTCACCCCTCCACTTTGGGAAC	CAWSVLGTEKNSPLHF	In	VDJ	7	492	0.0035097230742891384	0.005359477124183006	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	7	4	5	26	40	51	44	56			unresolved										Vb 20	CAWSVLGTEKNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCAGGGCTGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAQGWDTGELFF	In	VDJ	4	277	0.0019760026251587222	0.003017429193899782	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	3	0	5	26	-1	37	32	42													Vb 20	CAQGWDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAGGGGACCAGGCGGCCCAATTCACCCCTCCACTTTGGGAAC	CAWSEGTRRPNSPLHF	In	VDJ	3	194	0.0013839151959595384	0.002113289760348584	48	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	3	0	7	7	4	10	26	37	46	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEGTRRPNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATGTAGATACGCAGTATTTTGGCCCA	CAWSDVDTQYF	In	VJ	2	175	0.0012483771097573154	0.001906318082788671	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	1	0	0	5	0	4	26	-1	39	-1	43			unresolved										Vb 20	CAWSDVDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGACAGGCTGCGTACTCACCCCTCCACTTTGGGAAC	CAWSVGQAAYSPLHF	In	VDJ	2	170	0.001212709192335678	0.001851851851851852	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	4	10	0	8	26	-1	48	40	56			unresolved										Vb 20	CAWSVGQAAYSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGAACGAGGAGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	163	0.0011627741079453854		41	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	1	5	7	0	26	39	-1	46	51			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGGACAGGGACTGGGTACGAGCAGTACTTCGGGCCG	CAWRGTGTGYEQYF	In	VDJ	2	159	0.0011342397740080753	0.0017320261437908497	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	4	1	6	26	37	47	38	53			unresolved										Vb 20	CAWRGTGTGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAGGGGGCGCCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	130	9.273658529625772E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	0	1	0	4	26	-1	47	39	51													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCAAGACAGGGGACTATCAGCCCCAGCATTTTGGTGAT	CAWGKTGDYQPQHF	In	VDJ	2	116	8.27495684181992E-4	0.0012636165577342047	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	5	5	3	26	35	48	40	51													Vb 20	CAWGKTGDYQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTGGGGACAGAGAAGAATTCATCCCTCCACTTTGGGAAC	CAWSVLGTEKNSSLHF	In	VDJ	2	112	7.989613502446819E-4	0.0012200435729847494	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	5	14	4	12	26	40	51	44	63													Vb 20	CAWSVLGTEKNSSLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCCGTCCTTAAGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	100	7.133583484327517E-4		43	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	7	2	11	0	26	38	-1	49	52			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACGTCGTCCCTACTGGAGCAGTACTTCGGGCCG	CAWGTSSLLEQYF	In	VDJ	1	96	6.848240144954416E-4	0.0010457516339869282	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	5	0	7	7	0	13	26	-1	40	35	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGTSSLLEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCACAGGGTCCTTTGGCTACACCTTCGGTTCG	CAWSITGSFGYTF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	7	3	5	26	38	47	41	52													Vb 20	CAWSITGSFGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGGCTCCTCGCCTTGATTCACCCCTCCACTTTGGGAAC	CAWSVGAPRLDSPLHF	In	VDJ	1	91	6.491560970738041E-4	9.912854030501089E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	5	2	8	0	12	26	-1	45	40	57			unresolved										Vb 20	CAWSVGAPRLDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGACCCCTTTCTTTACGAGCAGTACTTCGGGCCG	CAWRDPFLYEQYF	In	VDJ	1	89	6.34888930105149E-4	9.694989106753813E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	3	1	7	4	0	9	26	-1	41	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRDPFLYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAATGACAGGGGAACTGTCTATGGCTACACCTTCGGTTCG	CAWRNDRGTVYGYTF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	4	4	6	26	37	49	41	55													Vb 20	CAWRNDRGTVYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATAAGGACCCGGGGGGACGAGCAGTACTTCGGGCCG	CAWIRTRGDEQYF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	1	5	8	0	26	36	-1	44	51			unresolved										Vb 20	CAWIRTRGDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACGGGCTACGAGCAGTACTTCGGGCCG	CAWSVTGYEQYF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	4	3	2	0	26	40	-1	42	46						01,02							Vb 20	CAWSVTGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGACGGCAGCTACACTGAAGCTTTCTTTGGACAA	CAWTDGSYTEAFF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	2	7	3	2	7	26	36	41	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTDGSYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGAGGACTACACTGAAGCTTTCTTTGGACAA	CAWSGEDYTEAFF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	1	10	3	4	0	26	39	-1	43	48			unresolved			01,02							Vb 20	CAWSGEDYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGGGTCCGGGACCCCGGGCGGCTATGGCTACACCTTCGGTTCG	CAWGGSGTPGGYGYTF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	1	4	0	17	26	-1	41	35	58			unresolved										Vb 20	CAWGGSGTPGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGGGGGCCGACTATGGCTACACCTTCGGTTCG	CAWMGADYGYTF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	6	0	3	1	2	26	36	43	37	45													Vb 20	CAWMGADYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGCCAGGGGAGAGGCGAGCAGTACTTCGGGCCG	CAWSVGQGRGEQYF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	6	4	5	26	40	50	44	55			unresolved										Vb 20	CAWSVGQGRGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAATCGCTATGGGGCAGGGGCTGTTTTTTGGAGAA	CAWSEIAMGQGLFF	In	VDJ	1	39	2.7820975588877314E-4	4.2483660130718953E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	13	14	0	26	39	-1	53	58													Vb 20	CAWSEIAMGQGLFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAAACAGGGGTAGCTACACCTTCGGTTCG	CAWSANRGSYTF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	2	9	3	2	26	39	49	42	51													Vb 20	CAWSANRGSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATCTCTCGGGAGGTGAAAAACTGTTTTTTGGCAGT	CAWSHLSGGEKLFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	8	1	7	7	0	26	38	-1	45	52													Vb 20	CAWSHLSGGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCAGGGGGGGGAACTGTTTTTTGGCAGT	CAWSVQGGELFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	0	4	1	12	1	3	26	40	48	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQGGELFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCGACAGGGTATGGCTACACCTTCGGTTCG	CAWSVATGYGYTF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	5	3	0	26	40	-1	43	50													Vb 20	CAWSVATGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGGACTAGCGGGGGAGACGAGCAGTACTTCGGGCCG		Out	VDJ	6	412	0.002939036395542937		44	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	5	0	2	23	-1	51	39	53														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGACGGCCATGTTTGTGCGAGACCTATGGCTACACCTTCGGTTCG	CTSRRPCLCETYGYTF	In	VDJ	2	161	0.0011485069409767302	0.0017538126361655772	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	18	0	23	34	-1	52	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSRRPCLCETYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCTTTCCGGGGGCAATGGCTACACCTTCGGTTCG	CASSQDLSGGNGYTF	In	VDJ	2	109	7.775605997916993E-4	0.001187363834422658	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	0	6	0	6	7	1	23	40	53	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLSGGNGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGACCGACTTGTTTGTGCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC	CTSRPTCLCTKRANVLTF	In	VDJ	1	71	5.064844273872537E-4	7.734204793028323E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	2	10	5	3	16	23	34	41	37	57						01,02								CTSRPTCLCTKRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATTTGGCAACAGGGAGTGAAAAACTGTTTTTTGGCAGT	CTSSHLATGSEKLFF	In	VDJ	1	58	4.13747842090996E-4	6.318082788671023E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	3	7	7	2	23	37	50	44	52														CTSSHLATGSEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGTCCAGGCCCGTTCTATGGCTACACCTTCGGTTCG	CASSQDGPGPFYGYTF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	4	5	6	23	40	49	45	55														CASSQDGPGPFYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCTCCAATAGTTTGTGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSSNSLCRANVLTF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	5	8	5	5	8	23	35	43	40	51						01,02								CTSSSNSLCRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTGAGAACAGGGTCGAGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	1.8547317059251545E-4		49	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	5	6	6	23	39	51	45	57														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGATGCTGCGAGGAAGACGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	1.4267166968655033E-4		47	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	1	3	7	7	23	34	45	41	52														X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCTGATCCCGGGACAGCACATGGCTACACCTTCGGTTCG	CASSSDPGTAHGYTF	In	VDJ	6	391	0.002789231142372059	0.0042592592592592595	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	6	8	3	19	32	47	40	50													Vb 5.1	CASSSDPGTAHGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTGGCGGGGGCTGGGAAAAACTGTTTTTTGGCAGT	CASSLGGGWEKLFF	In	VDJ	3	224	0.0015979227004893639	0.0024400871459694987	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	7	2	8	4	4	19	31	42	35	46													Vb 5.1	CASSLGGGWEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTATCAACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSINRNTGELFF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	1	5	0	19	30	-1	35	39													Vb 5.1	CASSINRNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCTCCACTAGCGGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLSPLAGGQETQYF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	1	2	5	1	19	34	51	39	52													Vb 5.1	CASSLSPLAGGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTACTCCTGGCCGGGGAGGACTTTGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLLLAGEDFASTDTQYF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	60	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	1	0	11	8	19	33	50	44	58													Vb 5.1	CASSLLLAGEDFASTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCCCAAGCGGGGACAAGTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	1.640724201395329E-4		49	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	3	7	5	7	19	34	46	39	53													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGTTGGTACAACGCCGGGGAGCTGTTTTTTGGAGAA	CASSLGGWYNAGELFF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	6	2	6	0	11	19	-1	39	35	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGGWYNAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGATTGACCGGGTTTTTTAGCCAAGAGACCCAGTACTTCGGGCCA	CASRLTGFFSQETQYF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	4	1	2	8	19	34	40	36	48						01,02							Vb 5.1	CASRLTGFFSQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGAGGACAAGAAGACTCCTACGAGCAGTACTTCGGGCCG	CASGGQEDSYEQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	7	1	6	0	3	6	19	28	36	31	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASGGQEDSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAAACCGACAGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKTDRENTGELFF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	1	5	1	19	29	41	34	42													Vb 5.1	CASKTDRENTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCTTTTGATCTTTCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	75	5.350187613245638E-4		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	13	5	22	31	49	44	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGACGCAGGCTAGGGAAGCTTTCTTTGGACAA	CASSFGTQAREAFF	In	VDJ	3	182	0.0012983121941476082	0.0019825708061002177	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	0	7	8	1	10	25	39	45	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFGTQAREAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGTTCGGGTCAGGGGCTTGTACGAGCAGTACTTCGGGCCG	CASSSVRVRGLYEQYF	In	VDJ	2	169	0.0012055756088513504	0.001840958605664488	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	4	10	4	25	38	54	48	58													Vb 3	CASSSVRVRGLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACATTTGATCTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	169	0.0012055756088513504		55	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	7	25	37	53	49	60													Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGTCTGGCTCTCGAAATGAGCAGTTCTTCGGGCCA	CASSWSGSRNEQFF	In	VDJ	2	165	0.0011770412749140403	0.0017973856209150326	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	7	5	6	25	38	46	43	52													Vb 3	CASSWSGSRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTCCCTTTCTGGGGGATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	146	0.0010415031887118175		47	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	6	1	4	11	1	25	36	52	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGTTTCGGGACTAATACTCTTCGCACAGATACGCAGTATTTTGGCCCA	CASSLSFGTNTLRTDTQYF	In	VDJ	1	98	6.990911814640967E-4	0.0010675381263616558	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	9	1	6	9	24	39	52	45	61						01,02							Vb 3	CASSLSFGTNTLRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGCAGGGGGCGGTCACTGAAGCTTTCTTTGGACAA	CASSLRQGAVTEAFF	In	VDJ	1	85	6.06354596167839E-4	9.25925925925926E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	4	3	3	25	40	51	43	54													Vb 3	CASSLRQGAVTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACTAGCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSTSSQETQYF	In	VDJ	1	72	5.136180108715813E-4	7.84313725490196E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	7	1	1	2	25	36	43	37	45						01,02							Vb 3	CASSTSSQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTCCCAGGGACAGATATACTCCGTGGCTACACCTTCGGTTCG	CASTFPGTDILRGYTF	In	VDJ	1	69	4.922172604185987E-4	7.516339869281046E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	5	7	8	10	25	35	50	43	60													Vb 3	CASTFPGTDILRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTCGGACAGGGGGGTTCTACGAGCAGTACTTCGGGCCG	CASTPRTGGFYEQYF	In	VDJ	1	66	4.708165099656161E-4	7.18954248366013E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	1	3	6	3	25	35	51	41	54													Vb 3	CASTPRTGGFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCGCCGGATTAAGGTATCATGGCTACACCTTCGGTTCG	CASAGLRYHGYTF	In	VDJ	1	63	4.4941575951263355E-4	6.862745098039216E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	8	1	8	6	3	10	25	34	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASAGLRYHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTCAGACAGGAAACCAGGATACGCAGTATTTTGGCCCA	CASQTGNQDTQYF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	2	4	6	3	7	25	33	42	36	49													Vb 3	CASQTGNQDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAGGGTAGGGGACAGCCGAACCTACAATGAGCAGTTCTTCGGGCCA	CASRVGDSRTYNEQFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	5	2	8	5	25	33	48	41	53													Vb 3	CASRVGDSRTYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCCCGGACTAGCCCGGCAGATACGCAGTATTTTGGCCCA	CASSLARTSPADTQYF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	7	4	4	4	25	40	52	44	56						01,02							Vb 3	CASSLARTSPADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGTTCAGGGGTAACACTGAAGCTTTCTTTGGACAA	CASTFRGNTEAFF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	2	2	4	1	25	35	45	39	46													Vb 3	CASTFRGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGAGGACAGGAGAGAAAACCGGGGAGCTGTTTTTTGGAGAA	CASSTRTGEKTGELFF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	5	4	7	25	37	48	41	55													Vb 3	CASSTRTGEKTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSSQGSGNTIYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	0	1	0	25	38	-1	39	45													Vb 3	CASSSQGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTTAGGGGGAAGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATLGGSAGANVLTF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	5	1	2	4	5	25	32	42	36	47													Vb 3	CATLGGSAGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTGGGACTCCCCGCTGGGAGTGGTGGCTACACCTTCGGTTCG	CASLGLPAGSGGYTF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	0	10	7	2	15	25	34	42	36	57						01,02							Vb 3	CASLGLPAGSGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCACGGGACTAGCGGGGGGGCAGGAGCAGTTCTTCGGGCCA	CASITGLAGGQEQFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	0	0	10	4	3	25	35	55	39	58													Vb 3	CASITGLAGGQEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCGCCCTGGAGCGGGGGCCGTAGGAATGAGCAGTTCTTCGGGCCA	CASSFAPWSGGRRNEQFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	2	7	10	7	25	39	57	49	64													Vb 3	CASSFAPWSGGRRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGCGGACAGGGTGGTCCTACGAGCAGTACTTCGGGCCG	CASGRTGWSYEQYF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	3	1	4	3	25	34	46	38	49													Vb 3	CASGRTGWSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCCCCTAAGGGCCCCACGGGGGGGCTACGAGCAGTACTTCGGGCCG	CASPLRAPRGGYEQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	0	3	14	0	18	28	-1	42	50														CASPLRAPRGGYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTGGTAGCGGGGGGGATCGGTGAGCAGTTCTTCGGGCCA	CASSLVAGGIGEQFF	In	VDJ	1	25	1.7833958710818793E-4	2.723311546840959E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	9	2	5	23	37	50	39	55													Vb 14	CASSLVAGGIGEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCTCTTTCGGGGGGTGAGCAGTTCTTCGGGCCA	CSASLSGGEQFF	In	VDJ	6	445	0.003174444650525745	0.004847494553376907	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	1	9	9	0	25	32	-1	41	48													Vb 4	CSASLSGGEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTTGGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEVWDSSYNEQFF	In	VDJ	4	307	0.0021900101296885477	0.003344226579520697	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	5	0	3	0	25	38	-1	41	48													Vb 4	CSVEVWDSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTTGGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CSALGQGNYGYTF	In	VDJ	4	260	0.0018547317059251544	0.002832244008714597	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	2	4	0	25	32	-1	36	46													Vb 4	CSALGQGNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATACAGGAGTAAACACTGAAGCTTTCTTTGGACAA	CSVDTGVNTEAFF	In	VDJ	2	164	0.0011699076914297127	0.0017864923747276688	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	2	1	4	25	36	42	37	46													Vb 4	CSVDTGVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCGGGTAGCGGGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	148	0.0010557703556804726		43	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	2	5	1	25	36	50	41	51													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATCACTGACGGTCGGGATGAAGCTTTCTTTGGACAA	CSVITDGRDEAFF	In	VDJ	1	101	7.204919319170792E-4	0.0011002178649237473	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	7	12	0	25	34	-1	46	51													Vb 4	CSVITDGRDEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGCCTCCTGACAATGAGCAGTTCTTCGGGCCA	CSVEGPPDNEQFF	In	VDJ	1	89	6.34888930105149E-4	9.694989106753813E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	9	0	5	0	6	25	-1	41	38	47													Vb 4	CSVEGPPDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATGTACTAGCGGGGCGGAGCAGTTCTTCGGGCCA	CSVECTSGAEQFF	In	VDJ	1	87	6.20621763136494E-4	9.477124183006536E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	3	10	3	2	25	37	50	40	52													Vb 4	CSVECTSGAEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGGCACAGGGTCCCTACGAGCAGTACTTCGGGCCG	CSVRAQGPYEQYF	In	VDJ	1	83	5.920874291991839E-4	9.041394335511983E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	2	5	2	25	34	45	39	47													Vb 4	CSVRAQGPYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGCGGACTAGCGGGGGGGAATGAGCAGTTCTTCGGGCCA	CSARGLAGGNEQFF	In	VDJ	1	75	5.350187613245638E-4	8.169934640522876E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	1	0	7	5	0	25	32	-1	37	52													Vb 4	CSARGLAGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAACAGGGGTGGCTATGGCTACACCTTCGGTTCG	CSVNRGGYGYTF	In	VDJ	1	72	5.136180108715813E-4	7.84313725490196E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	1	3	25	34	42	35	45													Vb 4	CSVNRGGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCATGGACCCAGGGACAGGGGAGGACTGAAGCTTTCTTTGGACAA	CSVEAWTQGQGRTEAFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	2	5	10	3	25	38	58	48	61													Vb 4	CSVEAWTQGQGRTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTGACAGGGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVLTGLNTGELFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	1	3	2	25	33	43	36	45													Vb 4	CSVLTGLNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACTAGCGGACTGGGCTACGAGCAGTACTTCGGGCCG	CSVGTSGLGYEQYF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	5	3	0	6	25	-1	45	35	51						01,02							Vb 4	CSVGTSGLGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACACAGGGGCGGGAACCGGGGAGCTGTTTTTTGGAGAA	CSVDTGAGTGELFF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	2	5	1	5	25	36	44	37	49													Vb 4	CSVDTGAGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCGGACAGGGGAAGGAAAAACTGTTTTTTGGCAGT	CSVLGQGKEKLFF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	2	8	3	3	25	34	46	37	49													Vb 4	CSVLGQGKEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAATGGGGGAATATCAGCCCCAGCATTTTGGTGAT	CSVGMGEYQPQHF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	6	1	5	4	3	25	35	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGMGEYQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGGACAGAATGAACACTGAAGCTTTCTTTGGACAA	CSVGDRMNTEAFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	2	2	25	33	42	35	44													Vb 4	CSVGDRMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGATGGGACAATCAGCCCCAGCATTTTGGTGAT	CSVGGWDNQPQHF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	0	8	3	1	5	25	35	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGWDNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCAGTCCTGGGGCCTACGAGCAGTACTTCGGGCCG	CSVVSPGAYEQYF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	4	6	2	2	8	0	25	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVSPGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGACAGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CSVQTGSQETQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	1	2	2	25	34	43	36	45													Vb 4	CSVQTGSQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGTGGCAGGACAATGAGCAGTTCTTCGGGCCA	CSVEEWQDNEQFF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	4	5	4	0	25	39	-1	43	47													Vb 4	CSVEEWQDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGCCGGGACTAGCGGAAAGTATTTTGGCCCA	CASSLAGTSGKYF	In	VDJ	3	227	0.0016193234509423464	0.0024727668845315903	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	5	13	1	2	18	35	47	36	49		TCRBV07-01,TCRBV07-02				01,02								CASSLAGTSGKYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCTAGTAGCAGCGGGTGAGCAGTACTTCGGGCCG	CASSLVAAGEQYF	In	VDJ	2	127	9.059651025095947E-4	0.001383442265795207	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	4	7	4	1	18	34	44	38	45		TCRBV07-02,TCRBV07-08				01,02								CASSLVAAGEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCCCACGAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	92	6.562896805581316E-4		38	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	5	2	8	2	6	1	22	34	42	40	43		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTACAGCAGGAACCTACGAGCAGTACTTCGGGCCG	CASSTAGTYEQYF	In	VDJ	1	69	4.922172604185987E-4	7.516339869281046E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	2	0	6	23	-1	39	35	45		TCRBV06-07,TCRBV06-08												CASSTAGTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCACGGGGGGACCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHGGTNTGELFF	In	VDJ	1	68	4.8508367693427115E-4	7.407407407407407E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	2	2	3	18	30	39	32	42		TCRBV11-01,TCRBV11-03												CASSHGGTNTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCGGGACAGGGAAGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGTGKGYSNQPQHF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	0	0	8	22	-1	43	34	51		TCRBV07-01,TCRBV07-08												CASSGTGKGYSNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCATCGTAGTGGGGTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	57	4.066142586066685E-4		40	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	7	6	2	3	7	3	23	33	44	40	47		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCCCTTACCAAACTAGCGGCCAATCGCCGGAAACCCAGTACTTCGGGCCA	CASSFPYQTSGQSPETQYF	In	VDJ	1	56	3.9948067512234097E-4	6.100217864923747E-4	57	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	3	5	8	10	13	18	32	50	42	63		TCRBV11-01,TCRBV11-03				01,02								CASSFPYQTSGQSPETQYF+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASGACTCGGCCCTGTATCTCTGTGCCAGCAGATCGGACGTGAACACTGAAGCTTTCTTTGGACAA	CASRSDVNTEAFF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	39	TCRBV05	unresolved					TCRBJ01	TCRBJ01-01	01	5	1	7	0	3	1	20	31	38	34	39		TCRBV05-04,TCRBV05-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSDVNTEAFF+TCRBV05-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGACGGTGCGGACCTACGAGCAGTACTTCGGGCCG	CASSLTVRTYEQYF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	2	6	1	19	33	43	39	44		TCRBV11-01,TCRBV11-03				01,02								CASSLTVRTYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTGCGGACGGGACAGGGGAGTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	2.4254183846713557E-4		50	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	4	7	4	22	35	52	42	56		TCRBV07-01,TCRBV07-04												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCRGCCATGTATCGCTGTGCTAGCAGCCCAGAGGTGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSPEVGQETQYF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-05	01	5	6	2	2	8	0	19	31	-1	39	43		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEVGQETQYF+TCRBV07-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCTGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSDSGTYNEQFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	2	1	1	23	40	44	41	45		TCRBV06-04,TCRBV06-08												CASSDSGTYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGGACTCMGCCRTGTATCKCTGTGCTAGCAGCCAGCGGACAGGTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	33	2.3540825498280805E-4		43	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	1	4	1	19	31	42	35	43		TCRBV07-07,TCRBV07-08												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGACGCGGAGCGAGCAGTACTTCGGGCCG	CASSYSTRSEQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	5	6	3	2	23	40	47	43	49		TCRBV06-04,TCRBV06-08				01,02								CASSYSTRSEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCTCCCATTGACCAATTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	32	2.2827467149848054E-4		46	TCRBV10	unresolved					TCRBJ01	TCRBJ01-04	01	6	2	7	4	8	5	23	34	45	42	50		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPDSNQPQHF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-05	01	5	1	7	1	2	0	23	35	-1	37	41		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDSNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCCCGGCCGCAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGRRGTGELFF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	4	8	0	18	30	-1	38	44		TCRBV07-05,TCRBV07-06												CASSPGRRGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCACCCAAGGGCAGGGACGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	1.712060036238604E-4		40	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	7	0	7	5	10	1	19	29	44	39	45		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGGGGCCTGGATGGAGAGACCCAGTACTTCGGGCCA	CASSYSGGLDGETQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	48	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	0	6	0	4	1	8	26	43	50	44	58		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGLDGETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCGACTAGTGGGTATGAGCAGTTCTTCGGGCCA	CASSPTSGYEQFF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	8	2	5	23	35	43	37	48		TCRBV06-04,TCRBV06-08				01,02								CASSPTSGYEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCTTGTGGAGGTAGCATATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.5693883665520537E-4		43	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	1	5	6	5	19	31	42	37	47		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTGGGGGACAGGTCGGTGAGCAGTTCTTCGGGCCA	CASSGGQVGEQFF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	9	2	4	23	35	45	37	49		TCRBV06-08,TCRBV06-09												CASSGGQVGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGCATCCTAGCACAGATACGCAGTATTTTGGCCCA	CASRHPSTDTQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	6	4	6	0	1	4	23	34	37	35	41		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRHPSTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAGCCACGTTTGGTGGCGACTCGGCYGTGTATCTCTGKGCCAGCAGCCCGGGGGGGGGAGATACCGGGGAGCTGTTTTTTGGAGAA	XASSPGGGDTGELFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	0	5	1	6	36	48	57	49	63		TCRBV07-02,TCRBV07-05												XASSPGGGDTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTTGGGCGGAGTGAAAAACTGTTTTTTGGCAGT	CASSFGRSEKLFF	In	VDJ	1	95	6.776904310111142E-4	0.0010348583877995642	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-04	01	5	8	0	7	3	4	23	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSFGRSEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGACGGCAGTAACTATGGCTACACCTTCGGTTCG	CASRDGSNYGYTF	In	VDJ	1	92	6.562896805581316E-4	0.0010021786492374729	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	6	1	7	1	0	5	23	-1	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRDGSNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGACTAGCGGCTATCCGAGTGAGCAGTTCTTCGGGCCA	CASSETSGYPSEQFF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	5	9	0	9	23	-1	46	37	55						01,02							Vb 22	CASSETSGYPSEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGACTACCACAGATACGCAGTATTTTGGCCCA	CASSETTTDTQYF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	9	2	0	1	23	-1	42	37	43						01,02							Vb 22	CASSETTTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGCAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGKNTGELFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-02	01	1	4	6	1	1	1	23	39	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEGKNTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTACTTCAGCTACGAGCAGTACTTCGGGCCG	CASSYFSYEQYF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	5	4	5	3	5	0	23	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSYFSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCCCCAGGGACTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSAPGTSGGNEQFF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	6	5	0	23	36	-1	41	55													Vb 22	CASSAPGTSGGNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGTCGGGATTCGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASGRDSPSTDTQYF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	3	0	3	7	23	32	40	35	47													Vb 22	CASGRDSPSTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAGGGCTCCGGTGCAGTTCTTCGGGCCA	CASSERAPVQFF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	2	5	3	12	0	7	23	-1	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSERAPVQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGAGCGGGGGGAAGAGATACGCAGTATTTTGGCCCA	CASSEGAGGRDTQYF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	1	5	1	3	23	39	49	40	52													Vb 22	CASSEGAGGRDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGAGGACTCAGCCATGTACTTCTGTGGAAAGATGTACGGCACAGATACGCAGTATTTTGGCCCA	CGKMYGTDTQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	13	2	8	1	0	10	23	-1	29	27	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CGKMYGTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCACCCCTAGTAGCGGGGGAAGCAATGAGCAGTTCTTCGGGCCA	CASTPSSGGSNEQFF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	6	7	3	28	38	54	45	57			01,02											CASTPSSGGSNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTTGTTGCGGACCTAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	187	0.0013339801115692456		46	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	4	1	7	4	7	4	26	39	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAATATATGAGTTCACCCCTCCACTTTGGGAAC	CASSEYMSSPLHF	In	VDJ	1	81	5.778202622305289E-4	8.823529411764706E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	2	9	8	0	26	38	-1	46	49														CASSEYMSSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD02-01*02	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGAGTAGGGGGTACAATTCACCCCTCCACTTTGGGAAC	CASSYSSRGYNSPLHF	In	VDJ	1	52	3.709463411850309E-4	5.664488017429193E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	5	1	7	4	3	26	43	53	47	56														CASSYSSRGYNSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTCCGGGACAGGGGTCGATGAGCAGTTCTTCGGGCCA	CASSSGTGVDEQFF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	8	4	3	26	37	51	41	54														CASSSGTGVDEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGGACAGCCTACACTGAAGCTTTCTTTGGACAA	CASSGTAYTEAFF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	3	0	3	26	-1	45	38	48														CASSGTAYTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATGGTTTTCAGGGGAAATAATTCACCCCTCCACTTTGGGAAC	CASMVFRGNNSPLHF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	4	2	5	7	2	26	36	49	43	51														CASMVFRGNNSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACCTGGACTAGCGGGGCCAAGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	1.640724201395329E-4		55	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	4	5	7	26	38	55	43	62														X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAACAGTTACGAGCAGTACTTCGGGCCG	CASSNSYEQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	4	1	1	26	38	43	39	44														CASSNSYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAAACTACAGAAGCAATGAAAAACTGTTTTTTGGCAGT	CASSLNYRSNEKLFF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	45	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-04	01	2	3	5	5	4	4	19	34	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNYRSNEKLFF+TCRBV07-07+TCRBJ01-04	TCRBV07-07*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTTGAATGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSFEWGYNEQFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-01	01	3	6	1	4	5	0	19	33	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFEWGYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTCGGTTCATAATGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSFGS**QSRANVLTF	Stop	VDJ	1	32	2.2827467149848054E-4		54	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	2	6	5	11	5	19	33	48	44	53														CASSFGS**QSRANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCCCAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSQGNTEAFF	In	VDJ	5	325	0.002318414632406443	0.003540305010893246	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	1	1	0	22	36	-1	37	42														CASSSQGNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTTGGCTGTGTATCTCTGTGCTACACGATCCCGGGGACAGGGGCAATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	144	0.0010272360217431626		47	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	0	2	3	12	4	22	27	49	39	53														X+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAATTGGGGATTTTCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	116	8.27495684181992E-4		43	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-01	01	4	0	8	6	6	6	22	35	45	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCAAGCCACGTTTGGTGGGGACTCGGCCAGTATCTCTGTGCCAGCAGCTCGGCGCCTTGGAGTAACACTGAAGCTTTCTTTGGACAA	CASSSAPWSNTEAFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	2	8	1	36	50	62	58	63														CASSSAPWSNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTGGGTAAGTTTGTGGAGCAGTACTTCGGGCCG	CASSEVGKFVEQYF	In	VDJ	2	152	0.0010843046896177825	0.0016557734204793028	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	2	0	9	7	2	10	23	38	43	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEVGKFVEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCTCCTTACCTGGAATGAGCAGTTCTTCGGGCCA	CASSELLTWNEQFF	In	VDJ	1	64	4.5654934299696107E-4	6.971677559912854E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	2	0	10	7	10	0	23	38	-1	48	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSELLTWNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAATCTCCAGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESPGNSNQPQHF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	0	5	2	23	37	47	42	49													Vb 12	CASSESPGNSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCCCCACCGACCGATGGGGTCAGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	3.2101125679473826E-4		43	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	11	6	2	7	13	5	24	30	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGCGGGTACAGGCGGAAGCTTTCTTTGGACAA	CAISESRVQAEAFF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	0	3	4	8	6	2	23	40	51	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESRVQAEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGTAAATTAAGTCAGGGGCAGGGTGAGCAGTTCTTCGGGCCA	CASKLSQGQGEQFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	4	2	9	11	5	24	31	48	42	53													Vb 12	CASKLSQGQGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGACGGAGGCCTCGAGCAGTACTTCGGGCCG	CAISDGGLEQYF	In	VDJ	1	28	1.9974033756117049E-4	3.0501089324618734E-4	36	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	6	1	3	24	38	44	39	47													Vb 12	CAISDGGLEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGTCAGGGGGGTTTTCTGAAGCTTTCTTTGGACAA	CAISESSGGFSEAFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	6	2	5	23	40	49	42	54													Vb 12	CAISESSGGFSEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	433	30588	0.2182020516186101		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	6	1	4	1	27	43	52	47	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTATGGGGCCGGGGGGACTACAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSSMGPGGLQTYNEQFF	In	VDJ	25	1793	0.012790515187399237	0.019531590413943357	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	2	13	4	24	37	57	50	61			01,02			01,02							Vb 17	CASSSMGPGGLQTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCAGAGCGCAGCAGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	21	1456	0.010386497553180865		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	6	6	3	5	7	27	35	44	40	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGCGGGGAAGCGGGGAGCTGTTTTTTGGAGAA	CASSIGRGSGELFF	In	VDJ	13	928	0.006619965473455936	0.010108932461873638	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	7	3	7	3	3	27	41	50	44	53			01,02										Vb 17	CASSIGRGSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGGACAGGGAAGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGQGRSNQPQHF	In	VDJ	9	660	0.004708165099656161	0.00718954248366013	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	1	3	4	27	39	50	42	54			01,02										Vb 17	CASSLGQGRSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAGATACGCAGTATTTTGGCCCA	CASSIGTDTQYF	In	VDJ	9	656	0.004679630765718851	0.007145969498910675	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	1	0	10	3	0	0	27	-1	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCAGGGAGGGTGGCCCAAATGAGCAGTTCTTCGGGCCA	CASSPREGGPNEQFF	In	VDJ	6	440	0.0031387767331041076	0.004793028322440087	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	7	5	7	27	38	50	43	57			01,02										Vb 17	CASSPREGGPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTCTAGCGGGGGACTACGAGCAGTACTTCGGGCCG	CASSVLAGDYEQYF	In	VDJ	5	320	0.0022827467149848053	0.003485838779956427	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	3	3	1	27	39	52	42	53			01,02										Vb 17	CASSVLAGDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLAGGTDTQYF	In	VDJ	4	273	0.0019474682912214122	0.002973856209150327	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	1	1	0	27	38	-1	39	49			01,02										Vb 17	CASSLAGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCAGGGGTTCGGCAGCCCCAGCATTTTGGTGAT	CASSSGVRQPQHF	In	VDJ	4	264	0.0018832660398624644	0.002875816993464052	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	7	1	5	27	39	46	40	51			01,02										Vb 17	CASSSGVRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGAAAATGGACACTGAAGCTTTCTTTGGACAA	CASSMGKMDTEAFF	In	VDJ	3	241	0.0017191936197229315	0.002625272331154684	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	8	3	1	6	27	41	46	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGKMDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCCAGGTCTCGGCTGAAAAACTGTTTTTTGGCAGT	CASQVSAEKLFF	In	VDJ	3	234	0.001669258535332639	0.0025490196078431374	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	4	4	7	3	7	27	33	40	36	47			01,02										Vb 17	CASQVSAEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCAGGGGAGTCCCGGTCACTGAAGCTTTCTTTGGACAA	CASSLRGVPVTEAFF	In	VDJ	3	207	0.001476651781255796	0.0022549019607843138	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	2	9	27	39	47	41	56			01,02										Vb 17	CASSLRGVPVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGAAGGGGGCGCTGAGCTCCGAGCAGTACTTCGGGCCG	CASSIKKGALSSEQYF	In	VDJ	3	193	0.0013767816124752108	0.00210239651416122	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	0	6	4	9	27	42	53	46	62			01,02										Vb 17	CASSIKKGALSSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTAGACTCGGATACGCAGTATTTTGGCCCA	CASSILDSDTQYF	In	VDJ	3	183	0.0013054457776319355	0.0019934640522875817	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	6	3	2	27	42	49	45	51			01,02			01,02							Vb 17	CASSILDSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTCAGCCCCCTCTGAAGCTTTCTTTGGACAA	CASSFSAPSEAFF	In	VDJ	3	177	0.0012626442767259705	0.0019281045751633986	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	5	6	4	6	27	39	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFSAPSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSIPGGYTEAFF	In	VDJ	2	171	0.0012198427758200055	0.0018627450980392157	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	3	2	1	27	42	51	44	52			01,02										Vb 17	CASSIPGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCGACAGYTTCTATCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	170	0.001212709192335678		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	6	1	4	1	34	50	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGCTAGCGGGGAGAAGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	164	0.0011699076914297127		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	8	6	6	27	39	54	45	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGAAGGGACTGAAAAACTGTTTTTTGGCAGT	CASSREGTEKLFF	In	VDJ	2	160	0.0011413733574924026	0.0017429193899782135	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	0	7	7	6	0	27	39	-1	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSREGTEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTAGGGACAGGGGACGAGCAGTACTTCGGGCCG	CASSILGTGDEQYF	In	VDJ	2	159	0.0011342397740080753	0.0017320261437908497	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	5	4	0	27	41	-1	45	55			01,02										Vb 17	CASSILGTGDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCCAGGGAGTCTATGGCTACACCTTCGGTTCG	CASSISQGVYGYTF	In	VDJ	2	157	0.0011199726070394201	0.001710239651416122	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	4	3	4	3	3	27	42	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISQGVYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAGGGGGACAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	153	0.00109143827310211		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	1	5	0	27	41	-1	46	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	138	9.844345208371973E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	6	1	4	1	34	50	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTAGCGGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGTYNEQFF	In	VDJ	2	120	8.560300181193021E-4	0.00130718954248366	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	8	0	2	1	1	27	43	48	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLAGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGTTCGTCTGGAGGCAACCAGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	119	8.488964346349745E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	10	1	9	9	6	27	36	50	45	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAAAGGGAACACAGATACGCAGTATTTTGGCCCA	CASSKGNTDTQYF	In	VDJ	2	113	8.060949337290094E-4	0.0012309368191721134	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	0	8	2	4	1	27	38	46	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSKGNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACTCGGCGAACACTGAAGCTTTCTTTGGACAA	CASSINSANTEAFF	In	VDJ	2	109	7.775605997916993E-4	0.001187363834422658	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	9	0	1	5	0	27	42	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSINSANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTAAAAAGGGGTTCGGTGAAGCTTTCTTTGGACAA	CASTPKKGFGEAFF	In	VDJ	1	96	6.848240144954416E-4	0.0010457516339869282	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	7	9	5	27	37	51	46	56			01,02										Vb 17	CASTPKKGFGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGCAGTGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSIEAVGYNEQFF	In	VDJ	1	87	6.20621763136494E-4	9.477124183006536E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	0	0	9	3	6	0	27	44	-1	50	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEAVGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCGGTCGGGCTGAAATCACCCCTCCACTTTGGGAAC	CASSIAVGLKSPLHF	In	VDJ	1	82	5.849538457148564E-4	8.932461873638344E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	8	0	10	7	5	27	41	52	48	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAVGLKSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGGACAGGGGAGGAACAGATACGCAGTATTTTGGCCCA	CASSGDRGGTDTQYF	In	VDJ	1	81	5.778202622305289E-4	8.823529411764706E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	3	2	4	27	38	50	40	54			01,02										Vb 17	CASSGDRGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCGACAGCTTTCTTCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	78	5.564195117775463E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	22	1	6	1	24	1	35	30	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTAGGGGAGGTAGCGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	5.207515943559087E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	3	3	10	0	27	38	-1	48	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATTCAGGAAACTATGGCTACACCTTCGGTTCG	CASSIDSGNYGYTF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	4	2	2	1	27	44	50	46	51			01,02										Vb 17	CASSIDSGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCACATTGTTAAGTAAGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	60	4.2801500905965105E-4		50	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	3	6	1	2	13	27	38	43	40	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGGGGGCCCAGACCCTATCTGGAAACACCATATATTTTGGAGAG	CASSIMGAQTLSGNTIYF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	6	0	1	2	10	27	42	50	44	60			01,02										Vb 17	CASSIMGAQTLSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGACCCGCTCATCGTGAAAAACTGTTTTTTGGCAGT	CASSGPAHREKLFF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	1	7	7	1	10	27	38	43	39	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGPAHREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCRMAGCTTTCTATCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	58	4.13747842090996E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	6	1	4	1	34	50	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTAGGACAGGCCGGCGAGCAGTACTTCGGGCCG	CASSMVGQAGEQYF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	6	4	4	27	41	52	45	56			01,02										Vb 17	CASSMVGQAGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGGAACCGGGACCAACAATGAGCAGTTCTTCGGGCCA	CASSWGTGTNNEQFF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	0	7	5	9	2	27	39	53	48	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWGTGTNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGACCGGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGPGSYNSPLHF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	6	1	7	0	1	4	27	38	43	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGPGSYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTTGTGGGGCCGGGGATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	45	3.2101125679473826E-4		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	12	7	0	0	4	8	27	32	41	36	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGTGGAGGCTAGCGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CAVEASGGSYEQYF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	4	1	1	7	0	27	33	-1	40	51			01,02										Vb 17	CAVEASGGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGCCCCTCTACAATGAGCAGTTCTTCGGGCCA	CASSIGGPLYNEQFF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	0	3	0	5	27	-1	48	43	53			01,02										Vb 17	CASSIGGPLYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCGACAGGGGGATCTCCTACGAGCAGTACTTCGGGCCG	CASSTDRGISYEQYF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	0	4	2	27	38	51	42	53			01,02										Vb 17	CASSTDRGISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCCTAAGGGACGGTACCTATGGCTACACCTTCGGTTCG	CASSFLRDGTYGYTF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	7	4	7	5	27	39	51	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFLRDGTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCGACAGCTTTCTATTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	35	2.496754219514631E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	20	1	6	1	22	1	35	32	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TTTGGTGCCAAAAGAACCCGACACTTTCTATCTCTGTGCCAGTAGTATAGGCTAGGACATGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	35	2.496754219514631E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	6	1	4	1	34	50	59	54	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAAGGTGCAATCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	2.496754219514631E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	7	5	4	0	2	8	27	37	42	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASTGTTGELFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	0	7	4	2	0	27	37	-1	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTGTTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGCCTCGTGAACACTGAAGCTTTCTTTGGACAA	CASSTGLVNTEAFF	In	VDJ	1	29	2.06873921045498E-4	3.159041394335512E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	0	0	5	27	-1	44	40	49			01,02										Vb 17	CASSTGLVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCACTAGCGGGGGGGCGATAGTGGATTGTACGCAGTATTTTGGCCCA		Out	VDJ	1	26	1.8547317059251545E-4		52	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	0	8	2	13	27	38	53	40	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGGACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDPNTGELFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	8	1	7	0	2	1	27	36	42	38	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSDPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCCGACAGGGGGGAGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	20	1.4267166968655033E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	1	9	4	3	27	38	51	42	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCATCCCAGGGGGCAATGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	1.355380862022228E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	6	6	4	27	44	58	50	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTCCGGGACAACCAAGAGACCCAGTACTTCGGGCCA	CASRFRDNQETQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	0	5	0	27	38	-1	43	49			01,02										Vb 17	CASRFRDNQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAATAAAACAGGGGCGGCCTACGAGCAGTACTTCGGGCCG	CASNKTGAAYEQYF	In	VDJ	2	111	7.918277667603544E-4	0.0012091503267973856	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	2	2	5	3	23	33	45	38	48													Vb 11	CASNKTGAAYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGGGTTCCCTTAATCAGCCCCAGTATTTTGGTGAT	CASSEGGSLNQPQYF	In	VDJ	1	95	6.776904310111142E-4	0.0010348583877995642	45	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-05	01	2	6	1	17	0	20	23	-1	43	38	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEGGSLNQPQYF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCACAGGGGGTCCGCCCAAGAGACCCAGTACTTCGGGCCA	CASSHRGSAQETQYF	In	VDJ	1	91	6.491560970738041E-4	9.912854030501089E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	1	1	1	5	23	35	44	36	49													Vb 11	CASSHRGSAQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGGCAGCACCTACGAGCAGTACTTCGGGCCG	CASSESGSTYEQYF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	1	8	0	2	1	4	23	39	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESGSTYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATACAGGGGGCTGGTATGGCTACACCTTCGGTTCG	CASSDTGGWYGYTF	In	VDJ	1	54	3.8521350815368593E-4	5.88235294117647E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	5	1	3	23	37	47	38	50													Vb 11	CASSDTGGWYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTCTTGACAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	3.1387767331041074E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	5	13	5	23	36	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGGGTCGGGGAATGAAGCTTTCTTTGGACAA	CASSDGSGNEAFF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	7	5	2	23	37	47	42	49													Vb 11	CASSDGSGNEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGGCGACAGGGTTCGGAAACACCATATATTTTGGAGAG	CASSEWATGFGNTIYF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	3	4	4	3	23	39	50	43	53													Vb 11	CASSEWATGFGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGGGGTAAAGGGGAGGGGGGTAAATTTGAAGAAAAACTGTTTTTTGGCAGT	CASRGKGEGGKFEEKLFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	0	8	8	13	23	34	49	42	62													Vb 7.1	CASRGKGEGGKFEEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGCCAGGGGGTACTGAAGCTTTCTTTGGACAA	CASSQPGGTEAFF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	5	2	1	23	37	46	39	47													Vb 7.1	CASSQPGGTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCAGAGACAGGGCAGGAGGAGGGCTACACCTTCGGTTCG	CASSPETGQEEGYTF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	8	0	9	23	-1	47	40	56													Vb 7.1	CASSPETGQEEGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAATCGGGAGGAGAGTCGACTAATGAAAAACTGTTTTTTGGCAGT	XASSQSGGESTNEKLFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	8	1	2	1	7	22	37	45	38	52													Vb 7.1	XASSQSGGESTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGGACAGGACAGCACACTGAAGCTTTCTTTGGACAA	CARTGQHTEAFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	36	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	1	5	3	4	1	23	31	41	35	42													Vb 7.1	CARTGQHTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGACGGGGGGGCTCTCCCGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	1.7833958710818793E-4		47	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	8	0	9	2	7	23	39	49	41	56													Vb 7.1	X+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTTCGGACTAGCGGGCCCGAAAGGGGGAGACCCAGTACTTCGGGCCA	CASSSD*RARKGETQYF	Stop	VDJ	1	40	2.8534333937310066E-4		51	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	4	5	2	11	26	38	51	40	62			01,02			01,02							Vb 12	CASSSD*RARKGETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCTCGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	2.1400750452982552E-4		38	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	4	1	0	26	43	-1	44	48			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCGCCGGGGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	1.640724201395329E-4		47	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	0	7	0	22	34	-1	41	48														X+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTTACGGACAGGGGGCGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	11	798	0.0056925996204933585		44	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	4	4	2	18	30	45	34	47														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCGGGAGGAGGACAGGAGGCACAGATACGCAGTATTTTGGCCCA	CATGRRTGGTDTQYF	In	VDJ	4	292	0.002083006377423635	0.0031808278867102397	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	4	1	7	2	18	27	41	34	43														CATGRRTGGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGAGCTCTACGGGATAATGAAAAACTGTTTTTTGGCAGT	CATRALRDNEKLFF	In	VDJ	4	290	0.00206873921045498	0.003159041394335512	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	8	3	4	7	0	18	29	-1	36	41														CATRALRDNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAACAGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRETGTGANVLTF	In	VDJ	3	224	0.0015979227004893639	0.0024400871459694987	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	3	3	2	1	1	18	35	42	36	43														CATSRETGTGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACAGGAGAGGCTAATGAAAAACTGTTTTTTGGCAGT	CATSTGEANEKLFF	In	VDJ	2	175	0.0012483771097573154	0.001906318082788671	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	4	4	4	3	0	5	18	-1	35	31	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSTGEANEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATCGGTAAGGGGCAGCCCCAGCATTTTGGTGAT	CATSRDIGKGQPQHF	In	VDJ	2	163	0.0011627741079453854	0.001775599128540305	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	7	8	0	18	35	-1	43	48														CATSRDIGKGQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCACGGGGGGATCAAGAGACCCAGTACTTCGGGCCA	CATSARGDQETQYF	In	VDJ	2	129	9.202322694782497E-4	0.0014052287581699347	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	2	3	2	18	30	40	33	42														CATSARGDQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTCCTGACCCTGAACACTGAAGCTTTCTTTGGACAA	CATSRDLLTLNTEAFF	In	VDJ	1	83	5.920874291991839E-4	9.041394335511983E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	2	7	0	6	2	18	35	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLLTLNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAGGACAGGAGGGGCAGATACGCAGTATTTTGGCCCA	CATSRRTGGADTQYF	In	VDJ	1	57	4.066142586066685E-4	6.209150326797386E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	4	4	1	5	18	33	41	34	46														CATSRRTGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCACGCGGTTCATCAGCCCCAGCATTTTGGTGAT	CATSRDHAVHQPQHF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	7	5	5	4	3	18	35	43	39	46						01,02								CATSRDHAVHQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTCGAGACAGGGGTCAAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	1.7833958710818793E-4		52	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	2	5	5	18	34	47	39	52														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACGTCGGGGTCATTGAGACCCAGTACTTCGGGCCA	CASSENVGVIETQYF	In	VDJ	50	3505	0.025003210112567946	0.03818082788671024	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	5	5	5	23	38	48	43	53		TCRBV06-01,TCRBV06-08												CASSENVGVIETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDISTDTQYF	In	VDJ	26	1856	0.013239930946911872	0.020217864923747275	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	9	0	0	2	26	-1	45	43	47		TCRBV03-01,TCRBV03-02				01,02								CASSQDISTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTCAGGGGAAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	15	1081	0.007711403746558046		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	2	3	4	26	43	52	46	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAACCAGGCAACGGGGGCCACAATGAGCAGTTCTTCGGGCCA	CSAQPGNGGHNEQFF	In	VDJ	9	664	0.0047366994335934715	0.007233115468409586	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	6	0	5	13	1	26	34	53	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQPGNGGHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGGACAGGATATCGGGAGGCTACACCTTCGGTTCG		Out	VDJ	8	580	0.00413747842090996		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	8	4	9	26	35	46	39	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCACCTACCCCGGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTYPGRNTGELFF	In	VDJ	6	457	0.0032600476523376755	0.004978213507625272	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	8	2	1	7	0	18	28	-1	35	41	TCRBV05,TCRBV11													CASTYPGRNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGTGATCTTACATTCCGAGGCTACACCTTCGGTTCG	CASSQDGDLTFRGYTF	In	VDJ	6	431	0.00307457448174516	0.0046949891067538125	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	3	6	8	10	6	26	43	56	53	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGDLTFRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGACTAGCGGGGGGTCACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	6	427	0.0030460401478078496		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	0	1	6	25	38	54	39	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCTACTTCCCACTCTGGAAACACCATATATTTTGGAGAG	CASSPTSHSGNTIYF	In	VDJ	5	353	0.0025181549699676135	0.0038453159041394337	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	3	10	0	2	5	23	36	41	38	46	TCRBV01,TCRBV04					01,02								CASSPTSHSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTTTCTCAGACAGTTGGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	342	0.002439685551640011		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	0	7	5	23	35	47	42	52	TCRBV02,TCRBV12													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCACCGGTAGGGGTCTGAATGAAAAACTGTTTTTTGGCAGT	CASSPTGRGLNEKLFF	In	VDJ	4	301	0.0021472086287825827	0.003278867102396514	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	5	8	4	23	36	49	44	53	TCRBV01,TCRBV04													CASSPTGRGLNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGGCGGATTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSEGGLSSYNSPLHF	In	VDJ	4	298	0.0021258078783296	0.003246187363834423	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	7	5	0	4	6	22	34	42	38	48	TCRBV02,TCRBV12					01,02								CASSEGGLSSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTCGCCGGGTCCACCTTCGGTTCG	CASSQGVAGSTF	In	VDJ	4	282	0.0020116705425803597	0.0030718954248366015	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	4	13	7	2	26	42	53	49	55		TCRBV03-01,TCRBV03-02				01,02								CASSQGVAGSTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCCGGGACAGGGTCCCTACTTCCATTACGCCCCTCCACTTTGGGAAC	CSAREGRDRVPTSITPLHF	In	VDJ	4	279	0.0019902697921273774	0.00303921568627451	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	3	13	5	17	24	38	52	43	69		TCRBV20-01,TCRBV20-or09_02												CSAREGRDRVPTSITPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACCCGGGACTAGCGGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSQPGTSGGNNEQFF	In	VDJ	4	279	0.0019902697921273774	0.00303921568627451	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	0	1	5	3	1	23	38	56	41	57	TCRBV01,TCRBV04													CASSQPGTSGGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTGACAGATAAAGCGGAAACACCATATATTTTGGAGAG		Out	VDJ	4	266	0.0018975332068311196		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	5	4	2	7	26	43	50	45	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCAGGGACAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRATGELFF	In	VDJ	4	248	0.0017691287041132243	0.0027015250544662308	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	4	1	1	23	35	45	36	46	TCRBV01,TCRBV04													CASSRDRATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGACTAGCGGGGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	3	245	0.0017477279536602416		46	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	1	2	4	1	1	26	42	56	43	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGACAGATACGAGCAGTACTTCGGGCCG	CSAGDRYEQYF	In	VDJ	3	243	0.0017334607866915867	0.0026470588235294116	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	4	1	1	26	35	43	36	44		TCRBV20-01,TCRBV20-or09_02												CSAGDRYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTGACCGGGACAGGGGGCAACACTGAAGCTTTCTTTGGACAA	CSARVTGTGGNTEAFF	In	VDJ	3	240	0.0017120600362386042	0.00261437908496732	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	2	7	0	26	37	-1	44	56		TCRBV20-01,TCRBV20-or09_02												CSARVTGTGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRYSNQPQHF	In	VDJ	3	236	0.0016835257023012941	0.002570806100217865	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	5	0	0	3	26	-1	40	37	43		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGTCAGGGTGGCAGGGAAACACCATATATTTTGGAGAG	CASSLSGWQGNTIYF	In	VDJ	3	234	0.001669258535332639	0.0025490196078431374	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	4	4	6	24	36	45	40	51	TCRBV24,TCRBV27													CASSLSGWQGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGAATGAAGCTTTCTTTGGACAA	CASSQDGNEAFF	In	VDJ	3	228	0.001626457034426674	0.0024836601307189543	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	8	7	1	1	26	43	48	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGNEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGATGTGGGCCCTTGATTCATCCCTCCACTTTGGGAAC		Out	VDJ	3	224	0.0015979227004893639		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	8	0	14	7	11	22	35	46	42	57	TCRBV07,TCRBV11													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGCAGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	189	0.0013482472785379008		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	5	4	0	26	43	-1	47	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCACAGGGCCCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTGPDSNQPQHF	In	VDJ	3	187	0.0013339801115692456	0.002037037037037037	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	0	0	5	23	-1	38	33	43	TCRBV09,TCRBV12													CASTGPDSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAAAGGGGCGTTGGTTGAGACCCAGTACTTCGGGCCA	CASKGALVETQYF	In	VDJ	2	166	0.0011841748583983679	0.0018082788671023966	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	11	5	2	5	4	8	24	31	40	35	48	TCRBV24,TCRBV27													CASKGALVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGTATCTCCCATTTGTAGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	166	0.0011841748583983679		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	7	5	16	1	26	39	59	55	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGTGGTGAGGTTCGGGATGAAAAACTGTTTTTTGGCAGT	CSASGGEVRDEKLFF	In	VDJ	2	164	0.0011699076914297127	0.0017864923747276688	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	8	4	6	13	0	26	37	-1	50	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGGEVRDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGATAGGGTTACCTACGAGCAGTACTTCGGGCCG	CASSQGDRVTYEQYF	In	VDJ	2	163	0.0011627741079453854	0.001775599128540305	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	8	2	0	8	26	-1	46	42	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDRVTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGAGGGGGCTTCCTATGGCTACACCTTCGGTTCG	CASSQDEGASYGYTF	In	VDJ	2	160	0.0011413733574924026	0.0017429193899782135	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	4	2	3	18	35	44	37	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDEGASYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTAGACCGAAGTAAATTAGGTTTCTTTGGACAA	CSASVDRSKLGFF	In	VDJ	2	152	0.0010843046896177825	0.0016557734204793028	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	7	13	4	14	26	37	44	41	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVDRSKLGFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
RGGACTCAGCYWTGTAYTTCTGTGCCAGCAACCCCCCTGGGACTAGCGGGGGCACAAGCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	151	0.0010771711061334551		61	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	0	2	0	8	7	20	30	52	38	59	TCRBV02,TCRBV09													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCCGGATTGGGCTATGGCTACACCTTCGGTTCG	CASSLAPGLGYGYTF	In	VDJ	2	150	0.0010700375226491276	0.0016339869281045752	45							TCRBJ01	TCRBJ01-02	01	0	0	9	4	9	0	18	35	-1	44	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPGLGYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTTCGGCCGTCCGGCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	149	0.0010629039391648		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	5	7	13	0	26	40	-1	53	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAGCCAGGGAGGGCTGAAAAACTGTTTTTTGGCAGT	CSARKPGRAEKLFF	In	VDJ	2	147	0.001048636772196145	0.0016013071895424837	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	0	7	6	1	26	38	51	44	52		TCRBV20-01,TCRBV20-or09_02												CSARKPGRAEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGACTCAGCTKTGTAYTTCTGTGCCAGCAACCCCCCTAGAACTAGCGGGGGCACAAGCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	143	0.001020102438258835		61	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	0	11	7	20	30	52	41	59	TCRBV09,TCRBV12													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAATATCAAGAGACCCAGTACTTCGGGCCA	CSAQYQETQYF	In	VDJ	2	142	0.0010129688547745074	0.0015468409586056645	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	4	6	2	0	4	26	-1	37	35	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATAGCCGGCTATCCGAACACTGAAGCTTTCTTTGGACAA	CASSIAGYPNTEAFF	In	VDJ	2	139	9.91568104321525E-4	0.001514161220043573	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	7	1	1	9	24	36	41	37	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSIAGYPNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGACAGGGCTACTTACTGAAGCTTTCTTTGGACAA	CSAPTGLLTEAFF	In	VDJ	2	135	9.630337703842148E-4	0.0014705882352941176	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	5	3	6	26	34	44	37	50		TCRBV20-01,TCRBV20-or09_02												CSAPTGLLTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGGGGACAGGAAAGAGACCCAGTACTTCGGGCCA	CASSGDRKETQYF	In	VDJ	2	132	9.416330199312322E-4	0.001437908496732026	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	3	0	1	23	-1	44	36	45	TCRBV02,TCRBV12													CASSGDRKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGCGGGCCTAATACGCAGTATTTTGGCCCA	CASSLAGGPNTQYF	In	VDJ	2	131	9.344994364469048E-4	0.0014270152505446623	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	7	2	4	18	35	42	37	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGGPNTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAGAGCGGGACAGGCTACACCTTCGGTTCG	CSAQSGTGYTF	In	VDJ	2	130	9.273658529625772E-4	0.0014161220043572985	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	6	3	8	4	2	26	34	45	38	47		TCRBV20-01,TCRBV20-or09_02												CSAQSGTGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGAGACGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSKRRLNTEAFF	In	VDJ	2	130	9.273658529625772E-4	0.0014161220043572985	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	2	7	0	4	3	26	38	45	42	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKRRLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCGGGGGGGCGCGGTGGATGAGCAGTTCTTCGGGCCA	CASSQARGGAVDEQFF	In	VDJ	2	129	9.202322694782497E-4	0.0014052287581699347	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	8	2	8	26	42	52	44	60		TCRBV03-01,TCRBV03-02												CASSQARGGAVDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCCAGGGTGGAACGGAGACCCAGTACTTCGGGCCA	CATSDPQGGTETQYF	In	VDJ	2	125	8.916979355409396E-4	0.0013616557734204794	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	5	4	7	24	38	47	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDPQGGTETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATCCCCACTCATAACAGCTACGAGCAGTACTTCGGGCCG	CSAIPTHNSYEQYF	In	VDJ	2	124	8.845643520566122E-4	0.0013507625272331154	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	5	3	14	0	26	34	-1	48	52		TCRBV20-01,TCRBV20-or09_02												CSAIPTHNSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATAGACAGGAGCGGAATATGGCTACACCTTCGGTTCG		Out	VDJ	2	124	8.845643520566122E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	5	4	7	26	34	44	38	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGGAGGCAGGTCTATGGCTACACCTTCGGTTCG	CASSLGRQVYGYTF	In	VDJ	2	122	8.702971850879571E-4	0.0013289760348583878	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	4	1	5	18	32	39	33	44	TCRBV07,TCRBV11													CASSLGRQVYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATCTGGGACAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSIWDRATGELFF	In	VDJ	2	122	8.702971850879571E-4	0.0013289760348583878	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	4	4	1	26	38	51	42	52		TCRBV12-03,TCRBV12-04												CASSIWDRATGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGATCAACAGGGCCGAGGTTTGGCCCAGTACTTCGGGCCA	CASSEDQQGRGLAQYF	In	VDJ	2	121	8.631636016036296E-4	0.001318082788671024	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	3	9	4	11	23	39	49	43	60	TCRBV02,TCRBV09													CASSEDQQGRGLAQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSQGGEKLFF	In	VDJ	2	121	8.631636016036296E-4	0.001318082788671024	36	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	6	1	8	0	0	26	-1	-1	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGGGTTCGGCTGGGGGGGGCAGAGAGACCCAGTACTTCGGGCCA	CASSSGSAGGGRETQYF	In	VDJ	2	119	8.488964346349745E-4	0.0012962962962962963	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	4	11	4	19	32	50	43	54	TCRBV07,TCRBV11													CASSSGSAGGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGATCAGGGATCACTGAAGCTTTCTTTGGACAA	CASSQGSGITEAFF	In	VDJ	2	111	7.918277667603544E-4	0.0012091503267973856	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	4	3	2	23	39	47	42	49	TCRBV01,TCRBV04													CASSQGSGITEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCTCCCCGGGGGCTCGTTCCATTCAGTACTTCGGCGCC	CSARPSPGARSIQYF	In	VDJ	2	111	7.918277667603544E-4	0.0012091503267973856	45	TCRBV20						TCRBJ02	TCRBJ02-04	01	2	6	0	9	8	6	26	38	52	46	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPSPGARSIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCCTAAACCGGGACAGGGGATCGACGAGCAGTACTTCGGGCCG	CASSPKPGQGIDEQYF	In	VDJ	2	110	7.846941832760269E-4	0.0011982570806100218	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	9	4	23	34	53	43	57	TCRBV02,TCRBV09													CASSPKPGQGIDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCGACGGAGCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	108	7.704270163073719E-4		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	2	0	5	2	18	31	40	36	42	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGCAGGCTCCCATCATACATCATAATTCACCCCTCCACTTTGGGAAC	CASSWQAPIIHHNSPLHF	In	VDJ	2	108	7.704270163073719E-4	0.001176470588235294	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	5	3	15	26	38	45	41	60		TCRBV03-01,TCRBV03-02												CASSWQAPIIHHNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTATTATTCACAGATACGCAGTATTTTGGCCCA	CASSLLFTDTQYF	In	VDJ	2	107	7.632934328230443E-4	0.0011655773420479302	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	9	2	0	5	24	-1	39	36	44		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLFTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCGCAAGGAAACTACAATGAGCAGTTCTTCGGGCCA	CASSSQGNYNEQFF	In	VDJ	1	106	7.561598493387168E-4	0.0011546840958605665	42	unresolved						TCRBJ02	TCRBJ02-01	01	3	1	8	3	5	2	19	32	40	37	42	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQGNYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTGGGTGGAGACACCCGCGAGCAGTACTTCGGGCCG	CASSLGGDTREQYF	In	VDJ	1	106	7.561598493387168E-4	0.0011546840958605665	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	2	6	6	9	4	18	30	43	39	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGDTREQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCTAAAAAAGCTTCTACAGGATTTCGATGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	105	7.490262658543893E-4		56	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	4	8	16	10	25	35	56	51	66		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCRGCCRTGTATSKCTGTGCTAGCAGCCACGCGCAGGAGATTATATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	103	7.347590988857342E-4		46	unresolved						TCRBJ02	TCRBJ02-07	01	5	4	4	4	6	9	18	30	40	36	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAACCAGGGCTGGGGCTATGGCTACACCTTCGGTTCG	CSASNQGWGYGYTF	In	VDJ	1	103	7.347590988857342E-4	0.0011220043572984749	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	4	4	6	26	37	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSASNQGWGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCAGGGAGGTTCGGGTAGGCTTGGAGACCCAGTACTTCGGGCCA	CSASREVRVGLETQYF	In	VDJ	1	103	7.347590988857342E-4	0.0011220043572984749	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	1	5	5	14	26	34	45	39	59		TCRBV20-01,TCRBV20-or09_02												CSASREVRVGLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTACCCCGGTGGTAAACTCCTACGAGCAGTACTTCGGGCCG	CSGTPVVNSYEQYF	In	VDJ	1	100	7.133583484327517E-4	0.0010893246187363835	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	8	5	0	6	7	26	33	42	39	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSGTPVVNSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCACTGGGGGGCAGGCCTACGAGCAGTACTTCGGGCCG	CASSPTGGQAYEQYF	In	VDJ	1	96	6.848240144954416E-4	0.0010457516339869282	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	6	0	2	7	3	18	30	43	37	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTGGQAYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTTCGGGATACGGGGGTAGCCCAGATACGCAGTATTTTGGCCCA	CSASSGYGGSPDTQYF	In	VDJ	1	96	6.848240144954416E-4	0.0010457516339869282	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	4	11	5	26	35	52	46	57		TCRBV20-01,TCRBV20-or09_02												CSASSGYGGSPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGACTAGCGGGTCCGCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGTSGSASNTGELFF	In	VDJ	1	95	6.776904310111142E-4	0.0010348583877995642	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	0	4	0	0	7	26	-1	47	35	54		TCRBV03-01,TCRBV03-02				01,02								CASGTSGSASNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCTCAGGGGATGACAAATGGCTACACCTTCGGTTCG	CASSLSQGMTNGYTF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	6	1	7	23	40	47	41	54	TCRBV24,TCRBV27													CASSLSQGMTNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACGGATGCCGCGTCCTACGAGCAGTACTTCGGGCCG	CASSETDAASYEQYF	In	VDJ	1	92	6.562896805581316E-4	0.0010021786492374729	45	TCRBV06						TCRBJ02	TCRBJ02-07	01	2	1	8	1	2	7	23	38	43	40	50		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETDAASYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAGGGCTAGCGGGGGTGTACTTCGGGCCG	CSALGLAGVYF	In	VDJ	1	92	6.562896805581316E-4	0.0010021786492374729	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	12	7	1	26	34	51	41	52		TCRBV20-01,TCRBV20-or09_02												CSALGLAGVYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CSAPRQGNQPQHF	In	VDJ	1	91	6.491560970738041E-4	9.912854030501089E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	4	4	0	26	35	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSAPRQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGCTAGCGGGGCTCAGGGGGGATACGCAGTATTTTGGCCCA	CASSLGLAGLRGDTQYF	In	VDJ	1	90	6.420225135894765E-4	9.80392156862745E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	6	6	9	24	36	51	42	60		TCRBV24-01,TCRBV24-or09_02												CASSLGLAGLRGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGCCAGGTCAGGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATRPGQGSSYNEQFF	In	VDJ	1	89	6.34888930105149E-4	9.694989106753813E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	0	7	3	24	35	47	42	50		TCRBV24-01,TCRBV24-or09_02												CATRPGQGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGTGGCGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSEWRGMNTEAFF	In	VDJ	1	88	6.277553466208215E-4	9.586056644880174E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	2	0	5	1	22	34	46	39	47	TCRBV02,TCRBV12													CASSEWRGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCCCCCAGACAGGGGAGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	87	6.20621763136494E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	2	5	6	4	23	32	46	38	50	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCAGGGGTCCTGGAAACACCATATATTTTGGAGAG	CASSLARGPGNTIYF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	2	2	0	2	18	-1	41	35	43	TCRBV07,TCRBV11													CASSLARGPGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGACATGGTTATGGCTACACCTTCGGTTCG	CASSPPGHGYGYTF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	5	4	4	26	39	49	43	53		TCRBV03-01,TCRBV03-02												CASSPPGHGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGACAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLDRATNEKLFF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	3	0	0	0	26	-1	-1	42	48		TCRBV12-03,TCRBV12-04												CASSLDRATNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGGGTCTAGGTACGAGCAGTACTTCGGGCCG	CASSQGGSRYEQYF	In	VDJ	1	85	6.06354596167839E-4	9.25925925925926E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	0	4	0	6	26	-1	47	42	53		TCRBV03-01,TCRBV03-02												CASSQGGSRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGACATAGGGGCCGCTGGCTACACCTTCGGTTCG	CASRDIGAAGYTF	In	VDJ	1	84	5.992210126835114E-4	9.150326797385621E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	6	7	0	10	23	-1	39	34	49	TCRBV24,TCRBV27													CASRDIGAAGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCGACAGGGCGACCGGGGAGCTGTTTTTTGGAGAA	CASSRDRATGELFF	In	VDJ	1	84	5.992210126835114E-4	9.150326797385621E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	5	2	2	23	36	45	38	47	TCRBV01,TCRBV04													CASSRDRATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGATAAATGAGAATGAGCAGTTCTTCGGGCCA	CASSLINENEQFF	In	VDJ	1	84	5.992210126835114E-4	9.150326797385621E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	2	7	7	0	26	40	-1	47	50		TCRBV12-03,TCRBV12-04												CASSLINENEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTCTCCGGGACAGGGCGAGGGGAGCAGTACTTCGGGCCG	CASSLSGTGRGEQYF	In	VDJ	1	83	5.920874291991839E-4	9.041394335511983E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	7	6	6	23	35	50	41	56	TCRBV24,TCRBV27													CASSLSGTGRGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTAGAGAGCTTCAGGGGGCCGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	82	5.849538457148564E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	4	6	4	18	35	49	41	53	TCRBV05,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGAACAGGGGCGAAAGGACCCCTCCACTTTGGGAAC	CSARTGAKGPLHF	In	VDJ	1	82	5.849538457148564E-4	8.932461873638344E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	2	12	0	7	26	-1	45	38	52		TCRBV20-01,TCRBV20-or09_02												CSARTGAKGPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGAAAGGTATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	80	5.706866787462013E-4		47	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	1	8	5	1	17	26	38	42	39	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCCAGATGGGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSARWGVTGELFF	In	VDJ	1	80	5.706866787462013E-4	8.714596949891067E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	9	1	4	8	1	26	37	51	45	52	TCRBV09,TCRBV12													CASSARWGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCGACAGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSRDRGSTDTQYF	In	VDJ	1	79	5.635530952618739E-4	8.60566448801743E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	2	2	3	23	36	46	38	49	TCRBV01,TCRBV04													CASSRDRGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACAAGAACAGGGCCGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSTRTGPPNEKLFF	In	VDJ	1	79	5.635530952618739E-4	8.60566448801743E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	3	6	4	26	38	50	44	54		TCRBV12-03,TCRBV12-04												CASSTRTGPPNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTACACATAGCCGGGGGCGCTTCCCCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	78	5.564195117775463E-4		55	unresolved						TCRBJ01	TCRBJ01-04	01	5	6	0	3	10	7	22	34	50	44	57	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCCTCGCGGGGCACACAGATACGCAGTATTTTGGCCCA	CASSRLAGHTDTQYF	In	VDJ	1	78	5.564195117775463E-4	8.496732026143791E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	3	2	7	2	26	37	50	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRLAGHTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGACGGACACCATGGGACAGATACGCAGTATTTTGGCCCA	CATSDGHHGTDTQYF	In	VDJ	1	75	5.350187613245638E-4	8.169934640522876E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	6	3	4	7	24	35	44	39	51		TCRBV24-01,TCRBV24-or09_02												CATSDGHHGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTACAGGCTCGGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	75	5.350187613245638E-4		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	7	3	5	26	40	48	43	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGGATGGGGGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	5.278851778402363E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	6	0	0	3	0	23	39	-1	42	48	TCRBV02,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGGGACCAAGGGGTTTGAGCAGTTCTTCGGGCCA	CASSLGTKGFEQFF	In	VDJ	1	74	5.278851778402363E-4	8.061002178649237E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	9	6	2	22	38	49	44	51		TCRBV12-03,TCRBV12-04												CASSLGTKGFEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTACTAGCGGGGGTGGCAGATACGCAGTATTTTGGCCCA	CSARVLAGVADTQYF	In	VDJ	1	74	5.278851778402363E-4	8.061002178649237E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	4	3	3	26	37	51	40	54		TCRBV20-01,TCRBV20-or09_02												CSARVLAGVADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGGACAGGGGAGAGACCTAGTACTTCGGGCCA	CSAWDRGET*YF	Stop	VDJ	1	74	5.278851778402363E-4		36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	12	2	8	26	34	46	36	54		TCRBV20-01,TCRBV20-or09_02												CSAWDRGET*YF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTCTGGGTTGGAATATGGACAATGAGCAGTTCTTCGGGCCA	CSTLGWNMDNEQFF	In	VDJ	1	74	5.278851778402363E-4	8.061002178649237E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	8	0	9	5	5	11	26	32	40	37	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTLGWNMDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VJ	1	73	5.207515943559087E-4		41	TCRBV03						TCRBJ01	TCRBJ01-04	01	3	0	0	0	0	4	26	-1	40	-1	44		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACCCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	72	5.136180108715813E-4		35	TCRBV20						TCRBJ01	TCRBJ01-03	01	5	1	7	2	0	2	26	-1	39	35	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACTAGCGGGGGGGTTTTTTACAATGAGCAGTTTTTCGGGCCA	CSARTSGGVFYNEQFF	In	VDJ	1	72	5.136180108715813E-4	7.84313725490196E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02			6	1	0	19	2	20	26	34	51	36	71		TCRBV20-01,TCRBV20-or09_02						TCRBJ02-01,TCRBJ02-05						CSARTSGGVFYNEQFF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD02-01*01	TCRBJ02	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTGGCGGAGCGGGCGCTACGAGCAGTACTTCGGGCCG	CASWRSGRYEQYF	In	VDJ	1	72	5.136180108715813E-4	7.84313725490196E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	6	4	3	8	2	24	31	45	39	47	TCRBV06,TCRBV10					01,02								CASWRSGRYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGGGGAGGGGGCAGGGTGACAGGAGATACGCAGTATTTTGGCCCA	CARGGGRVTGDTQYF	In	VDJ	1	71	5.064844273872537E-4	7.734204793028323E-4	45	TCRBV12						TCRBJ02	TCRBJ02-03	01	9	5	0	5	3	11	22	30	40	33	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARGGGRVTGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGGGACAGGCCAGCGAGCCCTGAAAAACTGTTTTTTGGCAGT	CSARDRPASPEKLFF	In	VDJ	1	71	5.064844273872537E-4	7.734204793028323E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	7	2	11	26	34	44	36	55		TCRBV20-01,TCRBV20-or09_02												CSARDRPASPEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGGGACAGGGCAAATTCACCCCTCCACTTTGGGAAC	CASSVGDRANSPLHF	In	VDJ	1	70	4.993508439029262E-4	7.625272331154684E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	3	7	0	2	23	-1	48	39	50	TCRBV09,TCRBV12													CASSVGDRANSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCTCCCAATGGGGGGCTACGAGCAGTACTTCGGGCCG	CASLPMGGYEQYF	In	VDJ	1	70	4.993508439029262E-4	7.625272331154684E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	9	1	3	8	0	23	32	-1	40	46	TCRBV06,TCRBV10													CASLPMGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTATCGGGATGGCTACACCTTCGGTTCG	CSANYRDGYTF	In	VDJ	1	70	4.993508439029262E-4	7.625272331154684E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	9	6	0	5	26	-1	40	36	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSANYRDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCAATTCCGGGACTAGCGGACATTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	68	4.8508367693427115E-4		53	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	0	5	2	8	6	24	33	52	41	58		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGTTCAACCCCCCAGGGGGACTATGGCTACACCTTCGGTTCG	CASSQGSTPQGDYGYTF	In	VDJ	1	68	4.8508367693427115E-4	7.407407407407407E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	3	11	0	23	39	-1	50	57	TCRBV01,TCRBV04													CASSQGSTPQGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACTACAGCGGGAGATACGCAGTATTTTGGCCCA	CASSTTAGDTQYF	In	VDJ	1	68	4.8508367693427115E-4	7.407407407407407E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	4	5	5	0	26	38	-1	43	49		TCRBV12-03,TCRBV12-04				01,02								CASSTTAGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGTTTACACTTYCACAGATACGCAGTATTTTGGCCCA	CASSLVYTXTDTQYF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	3	6	2	5	4	18	32	40	37	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVYTXTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACCCCCCGGGACCGTCGGGTACATTCAGTACTTCGGCGCC	CASRPPGTVGYIQYF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	45	unresolved						TCRBJ02	TCRBJ02-04	01	6	0	7	8	7	8	23	34	46	41	54	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPPGTVGYIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCAGGGATCGTAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSGIVTNEKLFF	In	VDJ	1	67	4.7795009344994363E-4	7.298474945533769E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	1	0	5	22	-1	40	35	45		TCRBV12-03,TCRBV12-04												CASSSGIVTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAGTATGGGGCCATGAAAAACTGTTTTTTGGCAGT	CASSQVWGHEKLFF	In	VDJ	1	66	4.708165099656161E-4	7.18954248366013E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	7	0	6	7	1	19	31	43	38	44		TCRBV05-06,TCRBV05-07												CASSQVWGHEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACAGGGGGAGGATATAGTGGCTACACCTTCGGTTCG	CASSLGTGGGYSGYTF	In	VDJ	1	65	4.636829264812886E-4	7.080610021786493E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	1	7	0	9	18	-1	44	34	53	TCRBV07,TCRBV11													CASSLGTGGGYSGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACTGGGATCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	65	4.636829264812886E-4		49	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	0	8	4	3	14	26	38	45	41	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCCCGGTCCCCTCAGGGACACCATATATTTTGGAGAG	CASSPGPLRDTIYF	In	VDJ	1	64	4.5654934299696107E-4	6.971677559912854E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	8	11	0	19	31	-1	42	47	TCRBV04,TCRBV05													CASSPGPLRDTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTGGTCGGGGGTCCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSFGRGSSYNSPLHF	In	VDJ	1	63	4.4941575951263355E-4	6.862745098039216E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	8	2	0	4	2	18	32	42	36	44	TCRBV07,TCRBV11													CASSFGRGSSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGAATACAGGGGGATGCGCAGTACTTCGGGCCG		Out	VDJ	1	63	4.4941575951263355E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	9	4	4	24	38	50	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCTCTTTGGACAGGGGAAAGCTAACTATGGCTACACCTTCGGTTCG	CSAILFGQGKANYGYTF	In	VDJ	1	63	4.4941575951263355E-4	6.862745098039216E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	0	8	4	26	36	53	44	57		TCRBV20-01,TCRBV20-or09_02												CSAILFGQGKANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACGGAAGCGCCAAGAGACCCAGTACTTCGGGCCA	CSARRKRQETQYF	In	VDJ	1	63	4.4941575951263355E-4	6.862745098039216E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	6	1	8	0	26	34	-1	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRKRQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACCGGGACTACAACACAATGAGCAGTTCTTCGGGCCA	CASSQGPGLQHNEQFF	In	VDJ	1	63	4.4941575951263355E-4	6.862745098039216E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	9	5	4	4	26	42	53	46	57		TCRBV03-01,TCRBV03-02				01,02								CASSQGPGLQHNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCTGATGTAGAGCCCCAGCATTTTGGTGAT	CASSPDVEPQHF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	5	8	8	8	0	23	34	-1	42	45	TCRBV02,TCRBV09					01,02								CASSPDVEPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAATGCCCGGGACAGAGATGAAGCTTTCTTTGGACAA	CAINARDRDEAFF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	5	7	9	3	23	30	46	39	49	TCRBV06,TCRBV10													CAINARDRDEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGCGGGACACGGCTACGAGCAGTACTTCGGGCCG	CASSEAGHGYEQYF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	3	3	2	5	22	34	43	36	48		TCRBV12-03,TCRBV12-04												CASSEAGHGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGCCAGGTGCACAGATACGCAGTATTTTGGCCCA	CASSPARCTDTQYF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	1	4	1	26	39	47	43	48		TCRBV03-01,TCRBV03-02												CASSPARCTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCGGTTTGAACTACGAGCAGTACTTCGGGCCG	CASSPPGLNYEQYF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	5	3	4	6	26	39	46	43	52		TCRBV03-01,TCRBV03-02				01,02								CASSPPGLNYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGACCTCTCACTCTGGAAACACCATATATTTTGGAGAG	CASSPTSHSGNTIYF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	45	TCRBV05						TCRBJ01	TCRBJ01-03	01	4	2	7	0	2	6	19	31	36	33	42		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTSHSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAACCCCGGGACAGGGGGTTGTGGCCCTCCACTTTGGGAAC	CASSQETPGQGVVALHF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	1	14	6	6	18	35	52	41	58	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQETPGQGVVALHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGGGGGGTCAGTAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQWGVSSNTGELFF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	9	1	2	1	8	26	41	48	42	56		TCRBV03-01,TCRBV03-02												CASSQWGVSSNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCCCCCTCGGGGCATCCGAGCAGTACTTCGGGCCG	CASSPLGASEQYF	In	VDJ	1	60	4.2801500905965105E-4	6.5359477124183E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	5	7	0	6	6	3	18	30	41	36	44	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGASEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTAATTGACAACCGGGACAGGAACCCCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	4.2801500905965105E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	4	0	12	6	24	32	52	44	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGAGACAGGGGGACGGAAGGGCAGTACTTCGGGCCG	CSGDRGTEGQYF	In	VDJ	1	60	4.2801500905965105E-4	6.5359477124183E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	1	9	2	8	26	33	44	35	52		TCRBV20-01,TCRBV20-or09_02												CSGDRGTEGQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCTCCCGGACTGAAGCTTTCTTTGGACAA	CSAISRTEAFF	In	VDJ	1	60	4.2801500905965105E-4	6.5359477124183E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	5	5	5	0	26	36	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSAISRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCGGACAGGGGTAGACGAGCAGTACTTCGGGCCG	CASSARTGVDEQYF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	5	4	3	24	36	49	40	52	TCRBV09,TCRBV21													CASSARTGVDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGTCATCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	59	4.2088142557532353E-4		44	TCRBV24						TCRBJ02	TCRBJ02-03	01	3	4	6	0	3	3	24	39	44	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCGCGGCTCTGGAAACACCATATATTTTGGAGAG	CASSRGSGNTIYF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	7	5	0	2	0	26	37	-1	39	43		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSRGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCAGAGCGGAACTAGCAAGGAGACCCAGTACTTCGGGCCA	CASSQDQSGTSKETQYF	In	VDJ	1	58	4.13747842090996E-4	6.318082788671023E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	3	7	5	10	3	23	40	56	50	59	TCRBV01,TCRBV04					01,02								CASSQDQSGTSKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCGCCGGGACAGGGGACCCCTCGCGCGGGATCCTCCACTTTGGGAAC	CASSAGTGDPSRGILHF	In	VDJ	1	56	3.9948067512234097E-4	6.100217864923747E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	15	4	16	23	34	48	38	64	TCRBV02,TCRBV21													CASSAGTGDPSRGILHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCGGGGGGACCCAGTACTTCGGGCCA	CASSLFGGTQYF	In	VDJ	1	56	3.9948067512234097E-4	6.100217864923747E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	7	5	0	24	36	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CASSLFGGTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCCCGAGGACAGGGGTGCATGGCTACACCTTCGGTTCG		Out	VDJ	1	56	3.9948067512234097E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	6	7	3	26	36	52	43	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGACTAGCGGGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSSTSGGATDTQYF	In	VDJ	1	56	3.9948067512234097E-4	6.100217864923747E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	2	1	3	26	39	52	40	55		TCRBV12-03,TCRBV12-04												CASSSTSGGATDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGAAATCGTTTCAGCCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	55	3.9234709163801345E-4		43	unresolved						TCRBJ02	TCRBJ02-05	01	4	4	5	5	10	2	23	36	49	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGGGGGTACTCAACGAGCAGTTCTTCGGGCCA	CSAGLAGVLNEQFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	10	0	8	26	-1	48	35	56		TCRBV20-01,TCRBV20-or09_02												CSAGLAGVLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGAAACAGCGGGGGCCAAATACGAGCAGTACTTCGGGCCG	CSAREETAGAKYEQYF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	6	2	4	6	5	26	40	54	46	59		TCRBV20-01,TCRBV20-or09_02												CSAREETAGAKYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCTCTGGGGGACCTGTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	3.9234709163801345E-4		53	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	0	7	4	9	4	26	43	57	52	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTTCACCCGGGACTAGCGGGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	54	3.8521350815368593E-4		53	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	4	11	0	24	36	-1	47	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTGCGACAGGACCGACCTCTGGTATGGCTACACCTTCGGTTCG	CSACDRTDLWYGYTF	In	VDJ	1	54	3.8521350815368593E-4	5.88235294117647E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	5	4	12	26	34	44	38	56		TCRBV20-01,TCRBV20-or09_02												CSACDRTDLWYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACTGACAGGGGGCAAAGTGAAAAACTGTTTTTTGGCAGT	CSATDRGQSEKLFF	In	VDJ	1	54	3.8521350815368593E-4	5.88235294117647E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	0	7	4	4	26	34	48	38	52		TCRBV20-01,TCRBV20-or09_02												CSATDRGQSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGAGGCTAGCGGGGGGTACTCCTACGAGCAGTACTTCGGGCCG	CASSLEASGGYSYEQYF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	0	5	2	18	32	48	37	50	TCRBV05,TCRBV11													CASSLEASGGYSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGATTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRFSNQPQHF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	2	8	0	1	2	26	38	41	39	43		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRFSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCCAGGGGGCAATTCACCCCTCCACTTTGGGAAC	CSAREPGGNSPLHF	In	VDJ	1	52	3.709463411850309E-4	5.664488017429193E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	0	7	2	0	26	40	-1	42	50		TCRBV20-01,TCRBV20-or09_02												CSAREPGGNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGAAACAGCCTACGAGCAGTACTTCGGGCCG	CASRETAYEQYF	In	VDJ	1	52	3.709463411850309E-4	5.664488017429193E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	5	2	4	0	26	37	-1	41	45		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRETAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGTTCTCTAGCGGGGAAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPFSSGEGSYNEQFF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	0	8	4	24	35	52	43	56		TCRBV24-01,TCRBV24-or09_02												CASSPFSSGEGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGCTTCAAAAATGCCTCACCCCTCCACTTTGGGAAC	CASSFKNASPLHF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	39	unresolved						TCRBJ01	TCRBJ01-06	01	6	4	6	10	3	8	23	34	39	37	47	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFKNASPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAGCGGTTGGACGGGCTTTCTTTGGACAA	CSALAVGRAFF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	5	11	1	8	26	34	42	35	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSALAVGRAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGTCCAGGGGCGGACGCAATGAGCAGTTCTTCGGGCCA	CASSPSRGGRNEQFF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	6	5	6	26	38	49	43	55		TCRBV12-03,TCRBV12-04												CASSPSRGGRNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGAGCGGGGGGGCATGATACGCAGTATTTTGGCCCA	CSGAGGHDTQYF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	0	6	1	3	26	33	44	34	47		TCRBV20-01,TCRBV20-or09_02												CSGAGGHDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGTGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CSASGGANQPQHF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	7	0	3	4	0	26	37	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSASGGANQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGTCCTCCCGGGACAGGGGGTATCAATGGCTACACCTTCGGTTCG	CSASPPGTGGINGYTF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	6	10	5	26	34	55	44	60		TCRBV20-01,TCRBV20-or09_02												CSASPPGTGGINGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGACGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSLADGRTDTQYF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	45							TCRBJ02	TCRBJ02-03	01	0	8	0	1	4	0	18	35	-1	39	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLADGRTDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCCAGGGGAACGGACCAGTATTTTGGCCCA	CATSSRGTDQYF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	12	2	7	24	36	44	38	51		TCRBV24-01,TCRBV24-or09_02												CATSSRGTDQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGATAACAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSQITGENTEAFF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	1	4	1	23	37	48	41	49	TCRBV01,TCRBV04													CASSQITGENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCTAGCAGCTTAGATCAAGAGACCCAGTACTTCGGGCCA	CASSLDQETQYF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	8	2	1	2	26	38	42	39	44		TCRBV03-01,TCRBV03-02				01,02								CASSLDQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGACTCGGTGCTGAAGCTTTCTTTGGACAA	CASSPGLGAEAFF	In	VDJ	1	49	3.4954559073204834E-4	5.337690631808279E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	1	10	6	3	5	26	38	46	41	51		TCRBV12-03,TCRBV12-04				01,02								CASSPGLGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCGCTGGGGGCGGGGGGCTACGAGCAGTACTTCGGGCCG	CASALGAGGYEQYF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	7	1	3	11	0	24	31	-1	42	50		TCRBV24-01,TCRBV24-or09_02												CASALGAGGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGCGGGGGACACAGATACGCAGTATTTTGGCCCA	CASAGDTDTQYF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	7	2	2	0	1	26	-1	42	35	43		TCRBV03-01,TCRBV03-02												CASAGDTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGGATCCACGTGCCCCACGGGAGACCCAGTACTTCGGGCCA	CASSQKDPRAPRETQYF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	51	TCRBV03						TCRBJ02	TCRBJ02-05	01	2	1	8	5	2	16	26	41	46	43	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKDPRAPRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCGAGACTAGCGGGGGGCCAGAGTCCGTACTTCGGGCCG	CASSPRLAGGQSPYF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	12	4	9	19	31	48	35	57		TCRBV05-06,TCRBV05-07												CASSPRLAGGQSPYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACATACAGGGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSEHTGGGTEAFF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	1	5	3	4	23	38	49	41	53		TCRBV06-01,TCRBV06-08												CASSEHTGGGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTGGGCAGGGGATCGCTGAAGCTTTCTTTGGACAA	CSAAGQGIAEAFF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	6	6	4	26	35	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSAAGQGIAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACCCAGCCCGGGACGGAGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	47	3.352784237633933E-4		46	TCRBV20						TCRBJ01	TCRBJ01-06	01	6	0	7	7	11	4	26	34	50	45	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCGGGACTAGCGGGGGACAAGAGACCCAGTACTTCGGGCCA	CSAPGTSGGQETQYF	In	VDJ	1	47	3.352784237633933E-4	5.119825708061002E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	2	4	1	26	34	52	38	53		TCRBV20-01,TCRBV20-or09_02												CSAPGTSGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAGCCCTTGGACCTCCTACGAGCAGTACTTCGGGCCG	CASSPWTSYEQYF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	6	1	7	0	5	0	20	31	-1	36	40	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWTSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCGCCGGGGGGGGCCCCACAGATACGCAGTATTTTGGCCCA	CAAGGGPTDTQYF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	11	8	0	2	2	4	22	28	38	30	42		TCRBV12-03,TCRBV12-04												CAAGGGPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTACAGGAGTAACAATCAGCCCCAGCATTTTGGTGAT	CASSQDYRSNNQPQHF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	4	3	2	5	23	40	47	42	52	TCRBV01,TCRBV04													CASSQDYRSNNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTACTTGCCGTCCTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLLAVLGANVLTF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	48	unresolved						TCRBJ02	TCRBJ02-06	01	2	10	0	4	3	7	26	41	46	44	53	TCRBV11,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLAVLGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAACTGGAGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGGGTGELFF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	5	1	5	5	1	26	41	52	46	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGGGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCCTGGGGGCGAATGAGCAGTTCTTCGGGCCA	CSARLGANEQFF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	7	6	1	26	34	46	40	47		TCRBV20-01,TCRBV20-or09_02												CSARLGANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTTTTTAGGAGCGGGGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSQFFRSGGNYNEQFF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	1	3	9	2	26	41	59	50	61		TCRBV03-01,TCRBV03-02												CASSQFFRSGGNYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGTCAGCAGCCCGCGGCTAGCGGGGGGGCCTGCAGATACGCAGTATTTTGGCCCA	CVSSPRLAGGPADTQYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	4	6	4	18	30	48	36	52	TCRBV07,TCRBV11													CVSSPRLAGGPADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATGATCCCAATACATATGAGCAGTACTTCGGGCCG	CAISDDPNTYEQYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	6	7	12	3	23	35	50	47	53	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDDPNTYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGCGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFAGGSYNEQFF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	0	3	0	24	36	-1	39	47		TCRBV24-01,TCRBV24-or09_02												CASSFAGGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGGAGGGGCCAATTCACCCCTCCACTTTGGGAAC	CATRGGANSPLHF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	9	9	0	7	2	3	24	33	42	35	45		TCRBV24-01,TCRBV24-or09_02												CATRGGANSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGCCGGGACAGGGGTCTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	3.1387767331041074E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	5	3	5	24	35	48	38	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGACAAGGCCTACGAGCAGTACTTCGGGCCG	CSATDKAYEQYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	5	4	2	2	0	26	40	-1	42	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDKAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAGACAGGGTGGGCGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	3.1387767331041074E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	5	2	8	26	43	52	45	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATGGTCACTCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	3.1387767331041074E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	4	6	13	26	38	47	44	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTCGACGGGGAGAACTATGGCTACACCTTCGGTTCG	CSARGLDGENYGYTF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	8	3	2	7	2	26	39	51	46	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLDGENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTATTGGTATCCCATTAAAAACATTCAGTACTTCGGCGCC	CASSYWYPIKNIQYF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	45	TCRBV03						TCRBJ02	TCRBJ02-04	01	5	0	10	4	4	9	26	38	44	42	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWYPIKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATCTAGGGGGGTGTCCCCTCACCCCTCCACTTTGGGAAC	CASSQDI*GGVPSPLHF	Stop	VDJ	1	43	3.067440898260832E-4		51	TCRBV03						TCRBJ01	TCRBJ01-06	01	0	5	1	10	5	8	26	43	54	48	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDI*GGVPSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCAAAGAGTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATQRVSSYNSPLHF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	9	11	2	0	4	4	24	33	40	37	44		TCRBV24-01,TCRBV24-or09_02												CATQRVSSYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTACCCGCCGGGACGGCAGGGACGAGCAGTACTTCGGGCCG	CASSTRRDGRDEQYF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	0	7	5	7	7	22	34	46	41	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRRDGRDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGATCCCCTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARGSPNSNQPQHF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	8	0	0	8	26	-1	41	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGSPNSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGGGGACTAGCGGGGGGGCCGTTTACAATGAGCAGTTCTTCGGGCCA	CASSKGTSGGAVYNEQFF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	4	3	5	26	38	57	41	62		TCRBV03-01,TCRBV03-02												CASSKGTSGGAVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCGGGAGCGGGGGGCGACTTTTGGAGAA	CSALRERGATF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	1	19	7	4	26	35	51	42	55		TCRBV20-01,TCRBV20-or09_02												CSALRERGATF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	40	2.8534333937310066E-4		37	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	0	10	0	0	0	26	-1	-1	39	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGCGGAGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRRRGSYNEQFF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	0	0	2	1	26	37	45	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRRGSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCGCCCAGGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASAQGSSGNTIYF	In	VDJ	1	39	2.7820975588877314E-4	4.2483660130718953E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	4	2	0	3	2	19	28	37	31	39		TCRBV05-06,TCRBV05-07												CASAQGSSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACTGGACAGGGTGGATATGGCTACACCTTCGGTTCG	CSAGTGQGGYGYTF	In	VDJ	1	39	2.7820975588877314E-4	4.2483660130718953E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	5	6	4	26	35	49	41	53		TCRBV20-01,TCRBV20-or09_02												CSAGTGQGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTTGGAGGAGACCCAGTACTTCGGGCCA	CSASLEETQYF	In	VDJ	1	39	2.7820975588877314E-4	4.2483660130718953E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	2	5	3	0	26	37	-1	40	44		TCRBV20-01,TCRBV20-or09_02												CSASLEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGACAGCCCACCTACGAGCAGTACTTCGGGCCG	CASSPGQPTYEQYF	In	VDJ	1	39	2.7820975588877314E-4	4.2483660130718953E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	2	3	4	26	38	47	41	51		TCRBV12-03,TCRBV12-04												CASSPGQPTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGCCCCGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGPRSSGNTIYF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	2	0	6	0	19	35	-1	41	45	TCRBV07,TCRBV11													CASSLGPRSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSLQGYTEAFF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	3	2	1	24	36	45	38	46		TCRBV24-01,TCRBV24-or09_02												CASSLQGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCCCTGGGACAGGGGAGGTGGCTACACCTTCGGTTCG	CASSPWDRGGGYTF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	7	4	3	24	36	50	40	53	TCRBV06,TCRBV24													CASSPWDRGGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCCCGGACAGGGGGCGGATGAGGGTGAGCAGTTCTTCGGGCCA	CRPGQGADEGEQFF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	1	0	9	4	9	26	31	46	35	55		TCRBV20-01,TCRBV20-or09_02												CRPGQGADEGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTTCTAGCGGGGGGGCCGCAGATACGCAGTATTTTGGCCCA	CASSPSSGGAADTQYF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	4	3	3	26	39	54	42	57		TCRBV03-01,TCRBV03-02												CASSPSSGGAADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTTCAGTTAAACAGGGGGCGGCCGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	37	2.6394258892011816E-4		59	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	3	0	4	10	4	22	37	56	47	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAGCGGGGGGGCCAGGGACGCAGTATTTTGGCCCA	CAISEAGGPGTQYF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	9	0	6	23	-1	47	40	53	TCRBV06,TCRBV10													CAISEAGGPGTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGACAGGGGATGCATCAGCCCCAGCATTTTGGTGAT	CSARDLGQGMHQPQHF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	2	5	4	4	26	40	53	44	57		TCRBV20-01,TCRBV20-or09_02												CSARDLGQGMHQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGCGGGGACGCACAGATACGCAGTATTTTGGCCCA	CSARDLRGRTDTQYF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	3	1	3	2	26	40	49	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDLRGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACTCAGCGGGGGCCCTGGGAAGAGACCCAGTACTTCGGGCCA	CSATQRGPWEETQYF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	6	2	3	5	7	26	34	47	39	54		TCRBV20-01,TCRBV20-or09_02												CSATQRGPWEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAAGGTCGGACAGGGGTCTACGAGCAGTACTTCGGGCCG	CSAEGRTGVYEQYF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	3	8	1	26	34	51	42	52		TCRBV20-01,TCRBV20-or09_02												CSAEGRTGVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCTAGCGGGGAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	2.496754219514631E-4		43	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	0	1	3	23	34	44	35	47	TCRBV09,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTTTTGGGCGGAGGAGAAGAGACCCAGTACTTCGGGCCA	CASSVLGGGEETQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	1	3	8	2	23	36	49	44	51	TCRBV02,TCRBV09													CASSVLGGGEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGCCCCAAGGCAGGGGGTGAAGGTACTTGGTATGGCTACACCTTCGGTTCG	CASSPKAGGEGTWYGYTF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	5	7	13	19	31	45	38	58	TCRBV05,TCRBV07													CASSPKAGGEGTWYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGCCCGGGACCCGGGGACACTGAAGCTTTCTTTGGACAA	CASSPGPGDTEAFF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	42							TCRBJ01	TCRBJ01-01	01	5	0	7	3	2	6	18	30	37	32	43	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPGDTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTCGGGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSAPLGGAYNEQFF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	2	5	0	26	35	-1	40	48		TCRBV20-01,TCRBV20-or09_02												CSAPLGGAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTTCCTGGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSPSWGDTDTQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	9	1	2	6	1	26	39	51	45	52		TCRBV03-01,TCRBV03-02												CASSPSWGDTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGTACACGGGACAGGGGGCTAGAGACCCAGTACTTCGGGCCA	CASSRTRDRGLETQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	0	4	8	1	26	37	57	45	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRTRDRGLETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCGGACAGGGGATGGCTACACCTTCGGTTCG	CASSPRTGDGYTF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	6	4	0	24	36	-1	40	49		TCRBV24-01,TCRBV24-or09_02												CASSPRTGDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGAAAGTCCGGGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSESPGLSGNTIYF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	48	unresolved						TCRBJ01	TCRBJ01-03	01	5	8	0	0	8	2	23	35	47	43	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESPGLSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCCCGATTGGCCGGAACCGGGTCCCAGTACTTCGGGCCA	CASSQDSRLAGTGSQYF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	9	18	1	26	43	65	61	66		TCRBV03-01,TCRBV03-02				01,02								CASSQDSRLAGTGSQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCGTCCAGACCGGGGAGCTGTTTTTTGGAGAA	CASSPVQTGELFF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	5	5	7	0	26	37	-1	44	47	TCRBV09,TCRBV12													CASSPVQTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAACCGACTGGACTATTAGTGAGGAAGAGCAGTACTTCGGGCCG	CSAQTDWTISEEEQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	9	7	11	11	26	34	51	45	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQTDWTISEEEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATCCCATCACAGGGACTCTACAACTATGGCTACACCTTCGGTTCG	CSAIPSQGLYNYGYTF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	48	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	3	3	2	9	7	26	34	49	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIPSQGLYNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGCCTAGGGCAGAGGAGAGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	2.3540825498280805E-4		47	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	1	10	2	2	6	4	20	36	46	42	50	TCRBV05,TCRBV07			TCRBD01,TCRBD02										X+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCCCGGGCAGATACGCAGTATTTTGGCCCA	CASSRADTQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	8	4	4	3	0	26	35	-1	38	42		TCRBV03-01,TCRBV03-02				01,02								CASSRADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGAGTCGGGGAGCTGTTTTTTGGAGAA	CASSPGVGELFF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	8	2	7	1	1	26	38	45	39	46		TCRBV12-03,TCRBV12-04												CASSPGVGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGATACCTCTCGGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLDTSRGGYNEQFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	3	8	0	26	42	-1	50	58		TCRBV12-03,TCRBV12-04												CASSLDTSRGGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCGAGGACTAGCGGGGGGTTCCGGGGAGCTGTTTTTTGGAGAA	CASSRGLAGGSGELFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	1	1	6	3	2	19	31	48	34	50	TCRBV07,TCRBV11													CASSRGLAGGSGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGCGGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLGRGLSYEQYF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	0	1	3	26	42	49	43	52		TCRBV12-03,TCRBV12-04												CASSLGRGLSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTCACAGGCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSSQAAGELFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	4	6	3	3	26	37	45	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSSQAAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYGGCYSTGTATCTCTGTGCCAGCAGCCAGGGAGGGAATAACTATGGCTACACCTTCGGTTCG	CASSQGGNNYGYTF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	1	2	2	19	31	40	33	42	TCRBV05,TCRBV07													CASSQGGNNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATTAGCCCTGGTGACTGGGGGTTAAATGAGCAGTTCTTCGGGCCA	CASSLISPGDWGLNEQFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	54	unresolved						TCRBJ02	TCRBJ02-01	01	2	6	1	7	16	3	18	33	54	49	57	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLISPGDWGLNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTAACGTTGAACACTGAAGCTTTCTTTGGACAA	CATSVTLNTEAFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	3	7	0	2	2	24	37	41	39	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVTLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACCACCGACAGGGGGCCCTCCAAGAGACCCAGTACTTCGGGCCA	CSAYHRQGALQETQYF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	0	1	7	3	26	35	52	42	55		TCRBV20-01,TCRBV20-or09_02												CSAYHRQGALQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGGGAGGCTGAAGCTTTCTTTGGACAA	CSARRGEAEAFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	1	6	0	4	26	-1	44	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGEAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGGGTAGGGGCGGGGGCCCGCAATGAGCAGTTCTTCGGGCCA	CASSPGVGAGARNEQFF	In	VDJ	1	30	2.1400750452982552E-4	3.26797385620915E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	2	6	12	4	26	38	57	50	61		TCRBV12-03,TCRBV12-04												CASSPGVGAGARNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGAGGGGGCAGGTTGATGAAAAACTGTTTTTTGGCAGT	CASRRGQVDEKLFF	In	VDJ	1	29	2.06873921045498E-4	3.159041394335512E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	0	6	1	6	23	34	42	35	48	TCRBV24,TCRBV27													CASRRGQVDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGGATCTGGCTACACCTTCGGTTCG	CASSLGGSGYTF	In	VDJ	1	29	2.06873921045498E-4	3.159041394335512E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	1	7	0	3	26	-1	46	40	49		TCRBV12-03,TCRBV12-04												CASSLGGSGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATCTCTGTGCCAGAAGCTTGGCCGACACTGGTGGGTCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	1.9974033756117049E-4		50				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	6	3	2	9	18	34	40	36	49	TCRBV05,TCRBV07	TCRBV05-03,TCRBV05-08,TCRBV07-02												X+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTCCGACAGGGAAATTCACCCCTCCACTTTGGGAAC	CASSLRQGNSPLHF	In	VDJ	1	28	1.9974033756117049E-4	3.0501089324618734E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	2	3	7	5	1	24	35	47	40	48		TCRBV24-01,TCRBV24-or09_02												CASSLRQGNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCTGGGGGGACAGGGGAAATAATTCACCCCTCCACTTTGGGAAC	CSAPWGDRGNNSPLHF	In	VDJ	1	28	1.9974033756117049E-4	3.0501089324618734E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	2	5	8	2	26	34	52	42	54		TCRBV20-01,TCRBV20-or09_02												CSAPWGDRGNNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTAGGTGCGGCAGATCAAGAGGAGACCCAGTACTTCGGGCCA	CASSLVGAADQEETQYF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	5	5	5	11	18	34	43	39	54	TCRBV07,TCRBV11					01,02								CASSLVGAADQEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGGGACAGGCGCTTGGACGGGGAGCTGTTTTTTGGAGAA	CASGDRRLDGELFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	0	4	7	3	8	24	31	42	34	50		TCRBV24-01,TCRBV24-or09_02												CASGDRRLDGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGTGCTGAGACGGGACAGGGAAATCAGCCCCAGCATTTTGGTGAT	CGAETGQGNQPQHF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	4	5	1	26	35	49	40	50		TCRBV20-01,TCRBV20-or09_02												CGAETGQGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTTAGTCTTTCCTATGGCTACACCTTCGGTTCG	CSAPLSLSYGYTF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	8	4	5	6	26	35	43	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPLSLSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCACCGGGACAGGGGGAGGATGGCTACACCTTCGGTTCG	CASSSPGQGEDGYTF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	1	6	5	3	26	38	54	43	57		TCRBV03-01,TCRBV03-02												CASSSPGQGEDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGATTAATGTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	1.9260675407684297E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAGCCCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRSPTNTGELFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	6	7	0	2	4	26	39	44	41	48		TCRBV03-01,TCRBV03-02				01,02								CASSRSPTNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGAAAGGGGGCTATACGTAAGCTTTCTTTGGACAA	CASSQDGKGGYT*AFF	Stop	VDJ	1	27	1.9260675407684297E-4		48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	0	9	6	7	26	43	56	49	63		TCRBV03-01,TCRBV03-02												CASSQDGKGGYT*AFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCGACAGGGCGAGATCTGATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	1.9260675407684297E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	6	2	9	26	38	47	40	56		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTACAGCCAGGGGGATGGACAGATACGCAGTATTTTGGCCCA	CASSVQPGGWTDTQYF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	3	8	4	26	37	52	45	56	TCRBV12,TCRBV21													CASSVQPGGWTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGCTTAGAGGTAGGGCTGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	1.8547317059251545E-4		53	unresolved						TCRBJ02	TCRBJ02-01	01	0	5	3	3	8	5	19	36	48	44	53	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCGGGACAGACTACGAAAAACTGTTTTTTGGCAGT	CATSDSGTDYEKLFF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	5	8	2	5	24	40	49	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDSGTDYEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACTACAGGGAGAGGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	1.8547317059251545E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	7	5	7	26	34	45	39	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGAGGCGGCCGGGACAGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	1.8547317059251545E-4		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	8	10	0	26	38	-1	48	54		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCAAAGACTAGCGGGGGCTGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	1.7833958710818793E-4		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	3	4	3	23	34	50	38	53	TCRBV06,TCRBV10													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCACAGACAGGGGCCCGACACTGAAGCTTTCTTTGGACAA	CASSHRQGPDTEAFF	In	VDJ	1	25	1.7833958710818793E-4	2.723311546840959E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	3	5	4	22	33	46	38	50		TCRBV12-03,TCRBV12-04												CASSHRQGPDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCACAGCACAGATACGCAGTATTTTGGCCCA	CSAREHSTDTQYF	In	VDJ	1	25	1.7833958710818793E-4	2.723311546840959E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	3	7	0	2	0	26	40	-1	42	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREHSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGTAGGAGCCAAGGGAATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	1.7833958710818793E-4		49	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	0	8	6	13	2	26	40	57	53	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCCGGGACAGTTCAACACTGAAGCTTTCTTTGGACAA	CSARPPGQFNTEAFF	In	VDJ	1	25	1.7833958710818793E-4	2.723311546840959E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	2	5	3	26	38	50	43	53		TCRBV20-01,TCRBV20-or09_02												CSARPPGQFNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCATGTCCCGACCCCAGCGGGGCACTCTTGGGATACGCAGTATTTTGGCCCA	CASSHVPTPAGHSWDTQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	6	14	9	19	31	52	45	61	TCRBV05,TCRBV11													CASSHVPTPAGHSWDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAGGGGACGGGCAACTATGGCTACACCTTCGGTTCG	CASSQGTGNYGYTF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	2	0	6	19	-1	37	31	43	TCRBV05,TCRBV11													CASSQGTGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATGGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLWGDTGELFF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	2	6	2	3	1	2	18	33	38	34	40	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGDTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCAGCCCCGCCCCCAGAAACACCATATATTTTGGAGAG	CASSPAPRNTIYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	39	unresolved						TCRBJ01	TCRBJ01-03	01	5	4	6	5	8	0	18	30	-1	38	40	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAPRNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAATCCGGGACAGGGATGCAGCATTTTGGTGAT	CAISESGTGMQHF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	13	3	3	23	38	50	41	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISESGTGMQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATAAGCGGGGGGAATTACAATGAGCAGTTCTTCGGGCCA	CASSISGGNYNEQFF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	1	4	3	3	24	36	48	39	51		TCRBV24-01,TCRBV24-or09_02												CASSISGGNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCGCCATGGGGACAGACACAGATACGCAGTATTTTGGCCCA	CASAMGTDTDTQYF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	5	2	6	1	19	28	41	34	42		TCRBV05-06,TCRBV05-07												CASAMGTDTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTAAGGGGACAGGGCGTGCAGCCCCAGCATTTTGGTGAT	CASSLRGQGVQPQHF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	7	2	4	18	33	44	35	48	TCRBV05,TCRBV11													CASSLRGQGVQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCACGACAGGGTTGGGAAAGAGACCCAGTACTTCGGGCCA	CASSHDRVGKETQYF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	3	4	6	22	33	44	37	50		TCRBV12-03,TCRBV12-04												CASSHDRVGKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGGGGGGGGGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	23	1.640724201395329E-4		37	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	9	0	9	4	2	26	34	45	38	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGTAGGGTCTATCGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVGSIAGANVLTF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	1	4	9	2	3	3	26	42	48	45	51		TCRBV12-03,TCRBV12-04				01,02								CASSVGSIAGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGAGGGGCTGGGACACTGAAGCTTTCTTTGGACAA	CASSLRGWDTEAFF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	3	0	5	19	-1	39	34	44		TCRBV05-06,TCRBV05-07												CASSLRGWDTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGGGCCAACACGGGCAACGAGCAGTACTTCGGGCCG	XASRANTGNEQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	11	4	3	5	5	12	22	25	35	30	47	TCRBV04,TCRBV17			TCRBD01,TCRBD02										XASRANTGNEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCGCCTTATGGGGGCCTCAGGGGAAGAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	22	1.5693883665520537E-4		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	2	4	15	5	18	30	51	45	56	TCRBV07,TCRBV11													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCCTGATGACAGCCAACGGGGACGAGCAGTACTTCGGGCCG	CASSPLMTANGDEQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	48	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	2	5	5	9	9	22	33	47	42	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLMTANGDEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACGGACAGGGGTCCCCGGGGAGCTGTTTTTTGGAGAA	CASSQRTGVPGELFF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	6	1	3	23	38	48	39	51	TCRBV01,TCRBV04													CASSQRTGVPGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATAACTGCAGATACGCAGTATTTTGGCCCA	CSARITADTQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	10	4	3	1	26	38	44	41	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARITADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACGAATTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	1.5693883665520537E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	8	5	19	0	26	39	-1	58	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGCTGAAGTCAGAGACTACGAGCAGTACTTCGGGCCG	CASAEVRDYEQYF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	1	4	5	3	1	3	23	39	43	40	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAEVRDYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCTCCTGGGGGCCTTACACTGAAGCTTTCTTTGGACAA	CASSWGPYTEAFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	6	0	3	4	3	22	31	41	35	44		TCRBV12-03,TCRBV12-04												CASSWGPYTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCTCCAGGGATATACTACAATGAGCAGTTCTTCGGGCCA	CSARSPGIYYNEQFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	3	4	5	26	38	47	42	52		TCRBV20-01,TCRBV20-or09_02												CSARSPGIYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGTTTAAGGACCGGGGGGAGACAGCCCCAGCATTTTGGTGAT	CSARDLGLRTGGRQPQHF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	1	7	15	3	26	40	62	55	65		TCRBV20-01,TCRBV20-or09_02												CSARDLGLRTGGRQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCCGGGGCCCAGAAGGGGGACCCAGTACTTCGGGCCA	CASSFPGPRRGTQYF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	5	2	7	13	0	26	40	-1	53	58		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPGPRRGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGATCCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSVDPANTEAFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	4	5	1	8	1	26	37	48	45	49		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDPANTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGAAGGACAGACATATTCACCCCTCCACTTTGGGAAC	CASREGQTYSPLHF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	5	8	4	4	26	37	47	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASREGQTYSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTGGGTGTCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGVGNQPQHF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	0	8	6	2	4	0	19	35	-1	39	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLGVGNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCAGTTATCCGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLAVIRGQETQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	2	10	1	19	33	48	43	49	TCRBV05,TCRBV07,TCRBV11													CASSLAVIRGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTCGGTGCCTTGGAGTAACACTGAAGTTTTCTTTGGACAA	CASSSVPWSNTEVFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	13	9	12	19	32	45	41	57	TCRBV05,TCRBV07													CASSSVPWSNTEVFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCCCGAATAGCCGGGACAGGGGGTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.4267166968655033E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	1	4	11	2	19	31	53	42	55	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGACTAATCTTGGGACTAGCGTGGCAGAGACCCAGTACTTCGGGCCA	CASSLTNLGTSVAETQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	6	4	10	4	18	32	52	42	56	TCRBV07,TCRBV11					01,02								CASSLTNLGTSVAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCAGGGCGCGGGACTCAACAAGAGACCCAGTACTTCGGGCCA	CASSLAGRGTQQETQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	2	7	3	18	35	48	42	51	TCRBV05,TCRBV07,TCRBV11					01,02								CASSLAGRGTQQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGAGGCAGGGTCCGAGCAGTACTTCGGGCCG	CSARDQEAGSEQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	3	6	8	2	26	40	53	48	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQEAGSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCCCGGGGGGGGAGGGCACAGATACGCAGTATTTTGGCCCA	CSARDIPGGEGTDTQYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	1	5	4	26	40	53	45	57		TCRBV20-01,TCRBV20-or09_02												CSARDIPGGEGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTCCCCGGGGAGGTCTACAATGAGCAATTCTTCGGGCCA	CSAVPGEVYNEQFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	16	8	14	26	34	48	42	62		TCRBV20-01,TCRBV20-or09_02												CSAVPGEVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGGGACCCTATGGCTACACCTTCGGTTCG	CASSEGPYGYTF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	36	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	0	7	4	2	1	26	38	45	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCCCTCTATCTGGGGGGCGAGTATGGCTACACCTTCGGTTCG	CASSQSLYLGGEYGYTF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	51	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	6	0	5	13	3	26	40	59	53	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSLYLGGEYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCAGAGGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSSRGGKETQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	42	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	5	1	3	5	2	24	36	47	41	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGGKETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCACTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLSLAGTDTQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	5	1	0	0	23	-1	-1	40	48	TCRBV24,TCRBV27					01,02								CASSLSLAGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGGGTGGTACAGGAGGAAACACTGAAGCTTTCTTTGGACAA	CSARKGGTGGNTEAFF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	3	4	2	10	4	26	37	52	47	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARKGGTGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCTTATATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT	CASSRLYFWHHQPQHF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	9	0	5	12	3	26	39	54	51	57		TCRBV03-01,TCRBV03-02												CASSRLYFWHHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACTGACTGCCCGCAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	19	1.355380862022228E-4		52	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	2	10	1	2	8	23	40	46	42	54	TCRBV01,TCRBV04					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGGGGACAGAGAGCGGGGCTACGAGCAGTACTTCGGGCCG	CARSLGDRERGYEQYF	In	VDJ	13	900	0.006420225135894765	0.00980392156862745	48	TCRBV05	TCRBV05-03					TCRBJ02	TCRBJ02-07	01	0	0	5	3	0	9	18	-1	41	34	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARSLGDRERGYEQYF+TCRBV05-03+TCRBJ02-07	TCRBV05-03		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAGGACAGCGGTGTTAGTGGGACCTTCGGTTCG	CASSQDSGVSGTF	In	VDJ	2	123	8.774307685722846E-4	0.0013398692810457516	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	14	2	13	18	30	38	32	51														CASSQDSGVSGTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGCGGGGGGCCCGCCTACGAGCAGTACTTCGGGCCG	CASSLGGGPAYEQYF	In	VDJ	1	28	1.9974033756117049E-4	3.0501089324618734E-4	45	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	1	2	0	4	18	-1	42	34	46														CASSLGGGPAYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGTGGGGAAACACCATATATTTTGGAGAG	CASSLAWGNTIYF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-03	01	0	0	10	4	2	0	18	35	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAWGNTIYF+TCRBV07-02+TCRBJ01-03	TCRBV07-02*01		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGCGCCTTGGAGTAACACTGAAGCTTTCTTTGGACAA	CASSSAPWSNTEAFF	In	VDJ	245	17303	0.12343239502931903	0.18848583877995642	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	2	9	1	18	31	44	40	45														CASSSAPWSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGGGGGGCGATAATTCACCCCTCCACTTTGGGAAC	CASSPRGGDNSPLHF	In	VDJ	20	1399	0.009979883294574197	0.015239651416122005	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	4	1	5	2	4	18	30	39	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGGDNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCGAGCGGACAGGGCTATGAATGAGCAGTTCTTCGGGCCA	CASSSRADRAMNEQFF	In	VDJ	12	855	0.006099213879100027	0.009313725490196078	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	7	7	5	18	31	46	38	51														CASSSRADRAMNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACCGTGGGTAGAATATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	7	509	0.0036309939935227063		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	0	9	4	8	5	18	30	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACGGTGGGCAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLYGGQSSYNEQFF	In	VDJ	6	441	0.003145910316588435	0.004803921568627451	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	0	6	4	18	33	43	39	47														CASSLYGGQSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTCCCCTCTAGTAGCGTGACAACCGGGGAGCTGTTTTTTGGAGAA	CASSLFPSSSVTTGELFF	In	VDJ	4	303	0.002161475795751238	0.003300653594771242	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	6	5	11	5	18	33	49	44	54						01,02								CASSLFPSSSVTTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAGCGGGGGACAGGGGGCGCGAGCAGTACTTCGGGCCG	CASSKAGDRGREQYF	In	VDJ	4	282	0.0020116705425803597	0.0030718954248366015	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	6	7	1	18	30	49	37	50														CASSKAGDRGREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCAGGGACTAGCGGGGGTCGCGGCGAGCAGTACTTCGGGCCG	CASSPSGTSGGRGEQYF	In	VDJ	4	259	0.001847598122440827	0.002821350762527233	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	6	6	6	18	30	50	36	56														CASSPSGTSGGRGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCGGGACATCTCGGAACAGATACGCAGTATTTTGGCCCA	CASSPSGHLGTDTQYF	In	VDJ	4	252	0.0017976630380505342	0.0027450980392156863	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	3	5	7	18	30	41	35	48														CASSPSGHLGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGCCTGGGGAGCGGATAAATCAAGAGACCCAGTACTTCGGGCCA	CASSLPGERINQETQYF	In	VDJ	3	241	0.0017191936197229315	0.002625272331154684	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	2	10	6	18	30	45	40	51						01,02								CASSLPGERINQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAACCGGGGGCCCGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSRTGGPGGETQYF	In	VDJ	3	235	0.0016763921188169665	0.002559912854030501	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	4	13	0	18	30	-1	43	50														CASSRTGGPGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGGGGGGCAGTAGAACTGAAGCTTTCTTTGGACAA	CASSSPGGSRTEAFF	In	VDJ	3	229	0.0016335906179110013	0.0024945533769063183	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	1	5	3	7	18	31	41	34	48														CASSSPGGSRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLEGANTEAFF	In	VDJ	3	219	0.0015622547830677262	0.0023856209150326796	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	1	0	1	18	-1	40	35	41														CASSLEGANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAACAGGTTGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPNRLANTGELFF	In	VDJ	3	204	0.0014552510308028135	0.0022222222222222222	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	4	0	4	4	18	30	39	34	43														CASSPNRLANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGCCGGGGGGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASTAGGGTGELFF	In	VDJ	2	163	0.0011627741079453854	0.001775599128540305	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	0	5	4	2	18	28	40	32	42														CASTAGGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGAGGCGGGGCGTGGGGTTATACGAGCAGTACTTCGGGCCG	CASSLVRRGVGLYEQYF	In	VDJ	2	148	0.0010557703556804726	0.0016122004357298474	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	4	4	10	18	34	44	38	54														CASSLVRRGVGLYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCGGAGGGGCAGGGGATACGCAGTATTTTGGCCCA	CASSLPGGAGDTQYF	In	VDJ	2	146	0.0010415031887118175	0.0015904139433551199	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	6	4	6	18	32	42	36	48														CASSLPGGAGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTGACACCGAACACTGAAGCTTTCTTTGGACAA	CASSFLTPNTEAFF	In	VDJ	2	137	9.773009373528698E-4	0.0014923747276688454	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	1	3	2	18	32	39	35	41														CASSFLTPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTAAAGGGCGGCAGTAACTATGGCTACACCTTCGGTTCG	CASSQVKGGSNYGYTF	In	VDJ	2	134	9.559001868998873E-4	0.0014596949891067538	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	5	3	1	7	6	18	30	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVKGGSNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGGTAGCGGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSLGSGGANEQFF	In	VDJ	2	116	8.27495684181992E-4	0.0012636165577342047	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	6	5	1	18	30	46	35	47														CASSLGSGGANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGGACAGGGGGAATGAGCAGTTCTTCGGGCCA	CASSSRDRGNEQFF	In	VDJ	2	115	8.203621006976644E-4	0.001252723311546841	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	7	3	0	18	31	-1	34	45														CASSSRDRGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGGCTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSGASGYNEQFF	In	VDJ	2	115	8.203621006976644E-4	0.001252723311546841	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	4	4	4	0	18	30	-1	34	42						01,02								CASSGASGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATAAACCGGGAAATTCACCCCTCCACTTTGGGAAC	CASSYKPGNSPLHF	In	VDJ	2	111	7.918277667603544E-4	0.0012091503267973856	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	8	3	7	6	0	18	31	-1	37	42														CASSYKPGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTAGTGCGGGGGGGCCGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	109	7.775605997916993E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	0	4	4	3	18	27	40	31	43														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGCAGGATAATTCACCCCTCCACTTTGGGAAC	CASSLRQDNSPLHF	In	VDJ	1	101	7.204919319170792E-4	0.0011002178649237473	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	4	5	3	0	18	33	-1	36	40														CASSLRQDNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACAGGGGCGGGCTATGGCTACACCTTCGGTTCG	CASSPTGAGYGYTF	In	VDJ	1	99	7.062247649484242E-4	0.0010784313725490195	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	4	2	4	18	30	40	32	44														CASSPTGAGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCGGGACAATCCACAATGAGCAGTTCTTCGGGCCA	CASSLTGTIHNEQFF	In	VDJ	1	98	6.990911814640967E-4	0.0010675381263616558	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	6	5	3	4	18	33	42	36	46														CASSLTGTIHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGTTACGGGGGGTGAGACCCAGTACTTCGGGCCA	CASSLEVTGGETQYF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	1	5	5	1	18	35	47	40	48														CASSLEVTGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGACACTGTCTGCCGACAATGAGCAGTTCTTCGGGCCA	CASSTTLSADNEQFF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	5	2	10	18	30	36	32	46														CASSTTLSADNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTACAGGGGAGGCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	85	6.06354596167839E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	3	2	0	2	5	18	34	43	36	48														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAACCTCCTAGGCTCAGATACGCAGTATTTTGGCCCA	CASSSNLLGSDTQYF	In	VDJ	1	76	5.421523448088912E-4	8.278867102396514E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	8	4	8	3	18	31	43	39	46						01,02								CASSSNLLGSDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACAGGGGGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSHRGSNEKLFF	In	VDJ	1	74	5.278851778402363E-4	8.061002178649237E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	1	3	1	1	18	30	39	31	40														CASSHRGSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGGGACCCCGGGACAAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSFGGTPGQGGETQYF	In	VDJ	1	73	5.207515943559087E-4	7.952069716775599E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	0	6	4	12	6	18	32	50	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGTPGQGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGGGATCGGGTAATTCACCCCTCCACTTTGGGAAC	CASSLRGSGNSPLHF	In	VDJ	1	71	5.064844273872537E-4	7.734204793028323E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	5	2	6	1	6	18	32	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGSGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAGTAGGCCTATTTGGCGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	71	5.064844273872537E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	10	2	2	0	15	18	-1	38	34	53														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTACGGACAGGGGGCATGGGAGACCCAGTACTTCGGGCCA	CASSPYGQGAWETQYF	In	VDJ	1	71	5.064844273872537E-4	7.734204793028323E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	0	5	6	4	18	30	47	36	51														CASSPYGQGAWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTACCCGGACGGAAGAGACCCAGTACTTCGGGCCA	CASSRTRTEETQYF	In	VDJ	1	69	4.922172604185987E-4	7.516339869281046E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	1	7	3	7	2	18	30	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTRTEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCTCACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSFLTVNTEAFF	In	VDJ	1	68	4.8508367693427115E-4	7.407407407407407E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	0	4	0	18	32	-1	36	40														CASSFLTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGTCGCTTTGGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFGRFGGTGELFF	In	VDJ	1	65	4.636829264812886E-4	7.080610021786493E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	5	4	0	12	18	-1	35	32	47						01,02								CASSFGRFGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAACGATAGGGAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPNDRESSGNTIYF	In	VDJ	1	65	4.636829264812886E-4	7.080610021786493E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	8	0	10	3	18	30	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNDRESSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCATGGCGGGGAGGGATACGCAGTATTTTGGCCCA	CASSSMAGRDTQYF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	3	6	5	3	18	31	42	36	45						01,02								CASSSMAGRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGTGGGGGTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLSVGVSTDTQYF	In	VDJ	1	59	4.2088142557532353E-4	6.427015250544662E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	6	1	0	5	2	18	33	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSVGVSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATACCCCGAGGAGACTGAAGCTTTCTTTGGACAA	CASSPYPEETEAFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	5	11	0	18	30	-1	41	45														CASSPYPEETEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGTAGCGGGGGGAAGCTCCTACGAGCAGTACTTCGGGCCG	CASRVAGGSSYEQYF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	0	2	3	18	29	41	31	44														CASRVAGGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACAGACAGGGGGCGGAGAACACTGAAGCTTTCTTTGGACAA	CASSDRQGAENTEAFF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	1	4	3	18	30	44	34	47														CASSDRQGAENTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLGAGDNEQFF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	5	3	0	18	34	-1	37	43														CASSLGAGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGCAGGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRQGNTGELFF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	2	3	1	18	30	38	33	39														CASSRQGNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGCAGGGGGCCCGAGGGGAGCAGTTCTTCGGGCCA	CASSLWQGARGEQFF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	10	3	7	18	33	44	36	51														CASSLWQGARGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGGGGGAGAGTAGATACGAGCAGTACTTCGGGCCG	CASSSGLAGESRYEQYF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	4	1	8	18	31	46	32	54														CASSSGLAGESRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCGCGAACCGGACGCGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	3.1387767331041074E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	1	7	6	11	4	18	32	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCGAAAAGATTCACCCCTCCACTTTGGGAAC	CASSLGRKDSPLHF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	7	0	8	0	6	18	-1	37	32	43														CASSLGRKDSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAAATCAGGGGAGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	2.996105063417557E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	2	3	5	4	18	32	43	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAGGGGGGGTGGAACCAAAAACATTCAGTACTTCGGCGCC	CASSPRGGGTKNIQYF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	9	0	2	4	5	18	30	41	34	46														CASSPRGGGTKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACCCGCCGCAGCAGGAAACACCATATATTTTGGAGAG	CASSRPAAAGNTIYF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	2	7	4	1	11	18	30	34	31	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPAAAGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAGGCAGGGCGAACATGGCTACACCTTCGGTTCG	CASSPRQGEHGYTF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	6	6	5	18	30	41	36	46														CASSPRQGEHGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCGAGCACCAGGGGTAGGACCCAGTACTTCGGGCCA	CASSLPSTRGRTQYF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	7	8	3	18	33	47	41	50														CASSLPSTRGRTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTCCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSLVPPGTEAFF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	3	5	6	0	18	34	-1	40	45														CASSLVPPGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGGACACTAGCGGGGACCCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRTLAGTLSTDTQYF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	0	8	6	18	30	48	38	54														CASSPRTLAGTLSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACCGGGACACCTGAACACTGAAGCTTTCTTTGGACAA	CASSQPGHLNTEAFF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	5	2	18	30	41	35	43														CASSQPGHLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGTCCGACATTGATAAACTATGGCTACACCTTCGGTTCG	CASGPTLINYGYTF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	6	2	5	6	18	27	36	32	42														CASGPTLINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCGCCAGGGGGTAGGGACTGAAGCTTTCTTTGGACAA	CASSLDRQGVGTEAFF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	5	4	5	18	35	46	39	51														CASSLDRQGVGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAAGGGGGCTGTTTCAGCCCCAGCATTTTGGTGAT	CASSLERGLFQPQHF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	6	1	4	18	35	43	36	47														CASSLERGLFQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCGTCCACTAGACACTACGAGCAGTACTTCGGGCCG	CASSPSSTRHYEQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	8	3	9	3	18	30	44	39	47						01,02								CASSPSSTRHYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCGGGCGGGGGGGCTGATGAGCAGTTCTTCGGGCCA	CASSPPGGGADEQFF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	8	7	3	18	30	46	37	49														CASSPPGGGADEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTCCGTCGTCGCACTACGAGCAGTACTTCGGGCCG	CASSLIPSSHYEQYF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	4	6	3	12	0	18	33	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIPSSHYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCATGTTGGCTAGTTCGGATACGCAGTATTTTGGCCCA	CASSPMLASSDTQYF	In	VDJ	1	34	2.4254183846713557E-4	3.7037037037037035E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	8	6	10	4	18	30	44	40	48						01,02								CASSPMLASSDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCGACAGGGCAGAGAGACCCAGTACTTCGGGCCA	CASSFRQGRETQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	4	2	3	18	32	41	34	44														CASSFRQGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGGATCCCGCGTTCTTAACTATGGCTACACCTTCGGTTCG	CASSGSRVLNYGYTF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	6	1	8	1	1	11	18	29	33	30	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSRVLNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTGGACAGGGCCGTGGTGCCCGGGGAGCTGTTTTTTGGAGAA	CASSLDRAVVPGELFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	6	3	9	18	29	40	32	49														CASSLDRAVVPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACAGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSSTGGGTEAFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	1	4	1	3	18	31	41	32	44														CASSSTGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGAGGGGAGATACCGGGGAGCTGCTTTTTGGAGAA	CASSPGRGDTGELLF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	18	3	18	18	30	40	33	58														CASSPGRGDTGELLF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAAGAGGGGCGATAATTCACCCCTCCACTTTGGGAAC	CASSPKRGDNSPLHF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	5	2	5	6	2	18	30	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKRGDNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTAGTAGCCTCTCCCACAGATACGCAGTATTTTGGCCCA	CASSLVASPTDTQYF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	5	7	2	0	6	18	-1	38	34	44						01,02								CASSLVASPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTTTAAGCTCTAACTATGGCTACACCTTCGGTTCG	CASSLVLSSNYGYTF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	6	7	0	5	1	18	34	42	39	43						01,02								CASSLVLSSNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAAAGAAGGTTGGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	2.06873921045498E-4		50	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	1	8	0	2	12	18	30	35	32	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCGGGACGGTCAGGGCACCCCTCCACTTTGGGAAC		Out	VDJ	1	29	2.06873921045498E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	0	7	11	4	8	18	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCTTCTCCCGGGACAGGGGTAATCCCAAGAGACCCAGTACTTCGGGCCA	CASSLVLLPGQG*SQETQYF	Stop	VDJ	1	28	1.9974033756117049E-4		60	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	1	10	5	18	34	54	44	59														CASSLVLLPGQG*SQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAATAGCGGGGGGAAGAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.9974033756117049E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	5	1	3	1	5	18	28	39	29	44														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAACTAGCGGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSLKLAGGADTQYF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	0	4	2	1	18	33	48	35	49														CASSLKLAGGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGGCCACGACGAAAAGATCGCTCCTACGAGCAGTACTTCGGGCCG	CASRPRRKDRSYEQYF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	2	7	0	5	10	18	29	37	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRRKDRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATCGAACGGCGGGGGGAATCACAGATACGCAGTATTTTGGCCCA	CASSLDRTAGGITDTQYF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	1	2	10	3	18	32	50	42	53														CASSLDRTAGGITDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGACAGGTCGTCGCGAGCAGTACTTCGGGCCG	CASSLEGTGRREQYF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	4	6	1	6	18	35	44	36	50														CASSLEGTGRREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATCACCACCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	1.712060036238604E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	0	3	7	0	2	3	18	35	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCCACTAGCGGGGGGGCCAATGGGAGAACAATGAGCAGTTCTTCGGGCCA	CASSLPH*RGGQWENNEQFF	Stop	VDJ	1	24	1.712060036238604E-4		60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	3	0	5	4	11	18	33	50	37	61														CASSLPH*RGGQWENNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTTGGGGGACAGGGGCTATGGCTACACCTTCGGTTCG	CASSSLGDRGYGYTF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	4	6	0	18	31	-1	37	47														CASSSLGDRGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGAGGTCAGGGGGAAGCGGTGAGCAGTTCTTCGGGCCA	CASSSGRSGGSGEQFF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	9	9	6	18	31	47	40	53														CASSSGRSGGSGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTACTAGCGCCAGATACGCAGTATTTTGGCCCA	CASSLVLAPDTQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	6	4	1	1	18	34	42	35	43						01,02								CASSLVLAPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAGTTTTACGAACACTGAAGCTTTCTTTGGACAA	CASSSSFTNTEAFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	3	7	1	8	0	18	31	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSFTNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGTGGCGGGACAGGGGGCGAAAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	1.4267166968655033E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	5	9	6	18	30	51	39	57														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGGGGGCGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	20	1.4267166968655033E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	1	5	2	3	18	30	39	32	42														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACACTTGAGAGGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	1.4267166968655033E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	1	6	11	0	18	30	-1	41	47														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGCAGTCTGGTCTTGAGGGAAGCTTTCTTTGGACAA	CASSLGSLVLREAFF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	8	17	0	18	30	-1	47	51														CASSLGSLVLREAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGACAGGGGGCTGTATGGCTACACCTTCGGTTCG	CASSPGDRGLYGYTF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	5	4	2	18	30	46	34	48														CASSPGDRGLYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCTCCCAGGACAGGGGCGGACTTGGGTACGCAGTATTTTGGCCCA	CASGPPRTGADLGTQYF	In	VDJ	3	235	0.0016763921188169665	0.002559912854030501	51	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	8	7	10	26	38	54	45	64														CASGPPRTGADLGTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCCAACCGGGGGCGGGAGGGCAAAACAAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	129	9.202322694782497E-4		53	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	12	7	0	0	10	7	26	31	50	41	57														X+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCAAAGGGACTAGCGACTACAATGAGCAGTTCTTCGGGCCA	CASTKGTSDYNEQFF	In	VDJ	2	121	8.631636016036296E-4	0.001318082788671024	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	0	6	3	10	1	26	31	51	41	52						01,02								CASTKGTSDYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAAGCAGGCACGACGAGCAGTACTTCGGGCCG	CASGLSRHDEQYF	In	VDJ	1	61	4.3514859254397857E-4	6.644880174291939E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	5	3	4	26	40	47	43	51														CASGLSRHDEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	50	3.5667917421637585E-4		43	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	8	0	0	1	26	-1	48	43	49						01,02								X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAGATAGGGCAGCTAAATTCACCCCTCCACTTTGGGAAC	CASKIGQLNSPLHF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-06	01	12	5	3	7	9	6	26	31	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKIGQLNSPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATGACTAGCGGGGGAGATACGCAGTATTTTGGCCCA	CASMTSGGDTQYF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	2	2	5	6	0	26	31	-1	37	49														CASMTSGGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTAGAACGGACAGCAAGAAAGTAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	1.9974033756117049E-4		55	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	0	5	11	26	39	50	44	61														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTACTAAGTTGACCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASGFTKLTGTGDTEAFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	54	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	3	13	0	26	40	-1	53	63														CASGFTKLTGTGDTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCTTCGGACTAGCGGGGGTGGGGATACGCAGTATTTTGGCCCA	CASLRTSGGGDTQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	1	2	6	8	4	26	31	52	39	56														CASLRTSGGGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCAGGGGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSPGGTGNEKLFF	In	VDJ	9	665	0.004743833017077799	0.00724400871459695	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	5	5	0	20	33	-1	38	47														CASSPGGTGNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCTAGGCCTACTACCGGGGAGCTGTTTTTTGGAGAA	CASSQPRPTTGELFF	In	VDJ	2	127	9.059651025095947E-4	0.001383442265795207	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	8	5	1	7	20	35	40	36	47						01,02								CASSQPRPTTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAAACAGGGAAGGTACCATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQSNREGTIAKNIQYF	In	VDJ	2	107	7.632934328230443E-4	0.0011655773420479302	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	3	3	0	2	10	20	37	45	39	55														CASSQSNREGTIAKNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTGGGGCAGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLGQGNEKLFF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	4	5	0	20	33	-1	38	43														CASSLGQGNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCTCCCTGATTGGGGGACACCAAGGGGGTCCTTATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	54	3.8521350815368593E-4		59	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	6	4	11	15	20	29	46	40	61														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCCGTACTACGGGCTAGCGGGGGGCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	52	3.709463411850309E-4		52	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	4	1	2	11	2	20	29	51	40	53														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATAACCCGTTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	52	3.709463411850309E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	3	3	7	0	2	5	20	34	38	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGGTGAGTAGCGGGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	3.1387767331041074E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	5	1	4	7	0	20	35	-1	42	52														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCTGACTAAGCGGGACAGGGCGGYACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	38	2.710761724044456E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	3	2	9	5	20	29	47	38	52														X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAGTTCCTTTCCGGGATTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSQEFLSGILAKNIQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	8	3	0	11	4	20	35	51	46	55														CASSQEFLSGILAKNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGAATATTGTCGGGGGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRILSGGATNEKLFF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	0	11	2	20	31	49	42	51														CASSRILSGGATNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCCCCAGATCGATTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	1.9974033756117049E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	1	4	7	20	35	42	39	49														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAGGTTCACAGGGGGTGGATGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	27	1.9260675407684297E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	1	3	7	4	20	37	52	44	56														X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGGGGACAGCCCGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	1.640724201395329E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	5	6	2	5	20	35	44	37	49														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGATCCGGGACAGGCAGATACGCAGTATTTTGGCCCA	CASSPDPGQADTQYF	In	VDJ	22	1530	0.010914382731021102	0.016666666666666666	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	4	8	0	23	35	-1	43	51														CASSPDPGQADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGACCGCCGTTAATGAAAAACTGTTTTTTGGCAGT	CASSRTAVNEKLFF	In	VDJ	12	877	0.006256152715755232	0.009553376906318082	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	5	1	7	4	1	6	23	35	40	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTAVNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSSAGGTDTQYF	In	VDJ	6	453	0.003231513318400365	0.004934640522875817	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	1	3	0	23	40	-1	43	51														CASSYSSAGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCCTTTTAGCGGGGGGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	326	0.0023255482158907707		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	5	0	2	6	2	23	33	50	39	52														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGACTGGGGTGGAATTCACCCCTCCACTTTGGGAAC	CASSDRLGWNSPLHF	In	VDJ	5	323	0.002304147465437788	0.0035185185185185185	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	6	2	7	8	3	23	35	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDRLGWNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCAGTTCCAAGAGACCCAGTACTTCGGGCCA	CASSYGQFQETQYF	In	VDJ	4	305	0.0021757429627198926	0.0033224400871459695	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	8	0	1	0	4	23	-1	42	38	46														CASSYGQFQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGGCGACAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSPGDRVNEQFF	In	VDJ	4	267	0.0019046667903154472	0.0029084967320261437	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	6	6	1	23	35	48	41	49														CASSPGDRVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCCCCCTGGGCAGGGAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	3	228	0.001626457034426674		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	3	5	12	3	23	33	50	45	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTTGTTTCTCGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLVSRAYNEQFF	In	VDJ	3	216	0.0015408540326147437	0.002352941176470588	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	2	2	11	0	23	34	-1	45	48														CASSLVSRAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGACAGGGTAACGAGCTACACCTTCGGTTCG	CASSYSDRVTSYTF	In	VDJ	3	212	0.0015123196986774336	0.002309368191721133	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	9	1	6	23	40	48	41	54														CASSYSDRVTSYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACGCCCGAACCAGTGAACACTGAAGCTTTCTTTGGACAA	CAITPEPVNTEAFF	In	VDJ	3	190	0.0013553808620222283	0.0020697167755991284	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	5	0	12	0	23	30	-1	42	45														CAITPEPVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGACAGGGGGCGACCCAACTATGGCTACACCTTCGGTTCG	CASSPDRGRPNYGYTF	In	VDJ	3	190	0.0013553808620222283	0.0020697167755991284	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	2	2	5	23	35	48	37	53														CASSPDRGRPNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATATCGGGGTTCTCAGATACGCAGTATTTTGGCCCA	CASISGFSDTQYF	In	VDJ	3	182	0.0012983121941476082	0.0019825708061002177	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	3	4	3	4	23	33	41	36	45														CASISGFSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCAGGTAGCCTCCTACGAGCAGTACTTCGGGCCG	CASSPQVASYEQYF	In	VDJ	3	182	0.0012983121941476082	0.0019825708061002177	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	4	4	0	4	4	23	34	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQVASYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCAGGAACCCTCACTCAAGCACAGATACGCAGTATTTTGGCCCA	CASSYSGRNPHSSTDTQYF	In	VDJ	2	169	0.0012055756088513504	0.001840958605664488	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	0	3	12	23	40	47	43	59														CASSYSGRNPHSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGACTAGCGGGGGGAATGGGGAGCTGTTTTTTGGAGAA	CASSRTSGGNGELFF	In	VDJ	2	152	0.0010843046896177825	0.0016557734204793028	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	1	1	8	1	3	23	35	50	36	53														CASSRTSGGNGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCACAGACAGGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	145	0.00103436960522749		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	1	5	2	23	35	46	40	48														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCCCCACCAGGAGGGGAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	136	9.701673538685423E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	4	9	3	23	40	55	49	58														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSYGMNTEAFF	In	VDJ	2	129	9.202322694782497E-4	0.0014052287581699347	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	9	0	0	0	1	23	-1	41	38	42														CASSYGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACCCGACAGGGGACGAGCAGTACTTCGGGCCG	CASSDPTGDEQYF	In	VDJ	2	123	8.774307685722846E-4	0.0013398692810457516	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	5	6	0	23	34	-1	40	48														CASSDPTGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCCCCTATAACACTGAAGCTTTCTTTGGACAA	CASSYSTPYNTEAFF	In	VDJ	2	117	8.346292676663195E-4	0.0012745098039215687	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	2	7	2	0	7	23	-1	43	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTPYNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGCGGGGGGCCGAAAACATTCAGTACTTCGGCGCC	CASERGAENIQYF	In	VDJ	2	115	8.203621006976644E-4	0.001252723311546841	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	8	6	1	5	1	3	23	32	42	33	45														CASERGAENIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGGACAGCAGAACACTGAAGCTTTCTTTGGACAA	CASSYPGQQNTEAFF	In	VDJ	2	114	8.13228517213337E-4	0.0012418300653594771	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	1	3	2	23	38	47	41	49														CASSYPGQQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCTACAAAGACAGTTCCTACGAGCAGTACTTCGGGCCG	CASSRYKDSSYEQYF	In	VDJ	2	114	8.13228517213337E-4	0.0012418300653594771	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	1	10	1	23	34	49	44	50														CASSRYKDSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCGCGGGCGGAGGGACTGAAGCGGGCTGGACAA	CASSSRAEGLKRA	In	VDJ	2	113	8.060949337290094E-4	0.0012309368191721134	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	19	12	9	23	34	52	46	61						01,02								CASSSRAEGLKRA+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTGACAGGGGGAAATTCACCCCTCCACTTTGGGAAC	CASLTGGNSPLHF	In	VDJ	2	109	7.775605997916993E-4	0.001187363834422658	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	2	1	7	2	1	23	32	43	34	44														CASLTGGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGGACTAGCGGGGAGATACGCAGTATTTTGGCCCA	CASSSRD*RGDTQYF	Stop	VDJ	1	105	7.490262658543893E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	5	3	0	23	36	-1	39	52														CASSSRD*RGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAAGAAGAGCGGGGCGACGAGCAGTACTTCGGGCCG	CASREEERGDEQYF	In	VDJ	1	104	7.418926823700618E-4	0.0011328976034858387	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	3	5	8	2	23	34	49	42	51														CASREEERGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGAGGCCTACTCTGGAAACACCATATATTTTGGAGAG	CASGEAYSGNTIYF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	8	9	1	0	1	4	23	32	39	33	43														CASGEAYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGGACAGGGCGTGAGGGCCTATGGCTACACCTTCGGTTCG	CASSPGQGVRAYGYTF	In	VDJ	1	93	6.634232640424591E-4	0.0010130718954248366	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	3	9	23	35	46	38	55														CASSPGQGVRAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGGAGGGGAAAAACTGTTTTTTGGCAGT	CASSRGGEKLFF	In	VDJ	1	91	6.491560970738041E-4	9.912854030501089E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	0	8	3	0	23	34	-1	37	44														CASSRGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCATAGCGGGGGGCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHSGGRSYNEQFF	In	VDJ	1	88	6.277553466208215E-4	9.586056644880174E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	0	2	2	23	35	47	37	49														CASSHSGGRSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACGGTTGCGGGGGGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSLRLRGGTYNEQFF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	2	8	2	23	35	52	43	54														CASSLRLRGGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTTGGCGGGGTCAACACAGATACGCAGTATTTTGGCCCA	CASSYLGGVNTDTQYF	In	VDJ	1	83	5.920874291991839E-4	9.041394335511983E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	3	2	4	4	23	38	48	42	52														CASSYLGGVNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGTACGGGGAGGAGACTGAAGCTTTCTTTGGACAA	CASSLYGEETEAFF	In	VDJ	1	81	5.778202622305289E-4	8.823529411764706E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	5	7	2	23	35	48	42	50														CASSLYGEETEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGATGGCACTGAAGCTTTCTTTGGACAA	CASSYSDGTEAFF	In	VDJ	1	78	5.564195117775463E-4	8.496732026143791E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	10	4	4	0	23	40	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCGACAGGCGGAGCACAGATACGCAGTATTTTGGCCCA	CASSYPDRRSTDTQYF	In	VDJ	1	76	5.421523448088912E-4	8.278867102396514E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	4	0	4	3	23	37	47	41	50														CASSYPDRRSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTCCGGGACTAGCGGGGATGGGTCGGCAGTTCTTCGGGCCA	CASSPPGLAGMGRQFF	In	VDJ	1	76	5.421523448088912E-4	8.278867102396514E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	12	6	8	23	34	53	40	61														CASSPPGLAGMGRQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAAGCCCTGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSASPGTGELFF	In	VDJ	1	75	5.350187613245638E-4	8.169934640522876E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	6	7	5	3	6	23	35	41	38	47						01,02								CASSASPGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGAGCTACCGGGGAGCTGTTTTTTGGAGAA	CASSYSGATGELFF	In	VDJ	1	73	5.207515943559087E-4	7.952069716775599E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	2	5	0	2	23	-1	45	40	47														CASSYSGATGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCCTACGAGCAGTACTTCGGGCCG	CASSYSSYEQYF	In	VJ	1	71	5.064844273872537E-4	7.734204793028323E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	0	0	0	0	23	-1	-1	-1	40														CASSYSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACGCTAGCGGAAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSTLAEAYNEQFF	In	VDJ	1	69	4.922172604185987E-4	7.516339869281046E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	2	4	3	23	34	45	38	48						01,02								CASSTLAEAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCTCCCGGGACAGGCCCCCCTACGAGCAGTACTTCGGGCCG	CASSSSRDRPPYEQYF	In	VDJ	1	66	4.708165099656161E-4	7.18954248366013E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	2	8	4	23	34	50	42	54														CASSSSRDRPPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGACCGATAAACACTGAAGCTTTCTTTGGACAA	CASSRPINTEAFF	In	VDJ	1	66	4.708165099656161E-4	7.18954248366013E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	2	7	2	2	5	23	34	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPINTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGGGAGTCACTAGCACAGATACGCAGTATTTTGGCCCA	CAIRGVTSTDTQYF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	0	0	5	23	-1	39	34	44														CAIRGVTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAGGGGAAGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASGGEGGLNTEAFF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	8	5	1	0	8	2	23	32	46	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGGEGGLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATTCAAGCGGGGGGGTGGAGCTGTTTTTTGGAGAA	CASNSSGGVELFF	In	VDJ	1	62	4.422821760283061E-4	6.753812636165577E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	6	0	10	5	1	23	33	48	38	49														CASNSSGGVELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACAGCGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASRTAGPTDTQYF	In	VDJ	1	60	4.2801500905965105E-4	6.5359477124183E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	3	2	3	2	23	34	44	37	46														CASRTAGPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGACGGGGGGCGATCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	57	4.066142586066685E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	2	5	5	23	34	46	39	51														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCAGTTCCAAAAGACCCAGTACTTCGGGCCA	CASSYGQFQKTQYF	In	VDJ	1	56	3.9948067512234097E-4	6.100217864923747E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	8	0	6	0	9	23	-1	42	38	51														CASSYGQFQKTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCAGGTTCAACCCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	3.9948067512234097E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	4	3	3	9	23	35	42	38	51														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGGGACATGATCAATTCACCCCTCCACTTTGGGAAC	CASTRDMINSPLHF	In	VDJ	1	50	3.5667917421637585E-4	5.446623093681918E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	0	6	7	3	5	23	33	42	36	47														CASTRDMINSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAATTACCGAGCGGGAGTCGGTAATTCACCCCTCCACTTTGGGAAC	CASSNYRAGVGNSPLHF	In	VDJ	1	48	3.424120072477208E-4	5.228758169934641E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	6	2	6	9	4	23	34	51	43	55														CASSNYRAGVGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGAATGGGACTCCTATCCCAGTACTTCGGGCCG	CASRGMGLLSQYF	In	VDJ	1	46	3.281448402790658E-4	5.010893246187364E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	10	6	7	23	34	46	40	53						01,02								CASRGMGLLSQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGGGACAGGGGACCTACGAGCAGTACTTCGGGCCG	CASSSPGQGTYEQYF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	2	4	1	23	36	50	40	51														CASSSPGQGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAAGGGAGGCACACCGGGGAGCTGTTTTTTGGAGAA	CASSYEGRHTGELFF	In	VDJ	1	45	3.2101125679473826E-4	4.901960784313725E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	9	1	3	3	1	23	38	47	41	48														CASSYEGRHTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGGACTAGCGGCGAGCACAGATACGCAGTATTTTGGCCCA	CASSYGGLAASTDTQYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	5	0	3	2	23	38	51	41	53						01,02								CASSYGGLAASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTATGGCTACACCTACGAGCAGTACTTCGGGCCG	CASSEYGYTYEQYF	In	VDJ	1	44	3.1387767331041074E-4	4.793028322440087E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	3	6	2	10	0	23	35	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEYGYTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCCCGGGGCACTGAAGCTTTCTTTGGACAA	CASSYSPRGTEAFF	In	VDJ	1	42	2.996105063417557E-4	4.5751633986928104E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	4	4	0	23	40	-1	44	49														CASSYSPRGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CAIRDSSYEQYF	In	VDJ	1	41	2.924769228574282E-4	4.466230936819172E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	5	0	3	0	23	30	-1	33	40														CAIRDSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTCGGGGACCGGGGCCCTCCGCGGAGCTGTTTTTTGGAGAA	CASIRGPGPSAELFF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	7	0	7	10	4	13	23	33	42	37	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIRGPGPSAELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGTCTAACAGGGTAGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	2.8534333937310066E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	1	5	4	23	36	47	41	51														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCATCTCGGAATCAGCCCCAGCATTTTGGTGAT	CASSPSRNQPQHF	In	VDJ	1	40	2.8534333937310066E-4	4.3572984749455336E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	4	6	0	23	35	-1	41	44						01,02								CASSPSRNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCTGGGGGGAGGTGAAAAACTGTTTTTTGGCAGT	CASSYSLGGGEKLFF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	9	1	7	3	3	23	40	49	43	52						01,02								CASSYSLGGGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGCCAGGACAAGAGACCCAGTACTTCGGGCCA	CASSVGPGQETQYF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	4	4	2	7	1	23	35	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGPGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCCGGGAGCCTATCTCCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSPPGSLSPLNTEAFF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	0	5	11	23	35	46	40	57														CASSPPGSLSPLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGGACTAGCGGGGGTTCTTGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGLAGVLGSYNEQFF	In	VDJ	1	37	2.6394258892011816E-4	4.0305010893246186E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	0	2	7	23	35	51	37	58														CASSQGLAGVLGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAATGGTACGAGGCAGGGAAGAAAGTCAGCCCCAGCATTTTGGTGAT	CASS*MVRGREESQPQHF	Stop	VDJ	1	36	2.5680900543579064E-4		54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	6	12	7	23	37	54	49	61														CASS*MVRGREESQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACGGCCAGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPRPEGNQPQHF	In	VDJ	1	36	2.5680900543579064E-4	3.92156862745098E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	1	2	9	0	23	35	-1	44	48														CASSPRPEGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGAACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSRTGAYEQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	2	4	0	23	34	-1	38	45														CASSRTGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGACAAGTGTTCTACGAGCAGTACTTCGGGCCG	CASRGQVFYEQYF	In	VDJ	1	35	2.496754219514631E-4	3.812636165577342E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	6	3	1	6	23	34	40	35	46														CASRGQVFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGGGGAAGGAGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	34	2.4254183846713557E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	6	0	6	23	-1	42	35	48														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCATTCCTACGAGCAGTACTTCGGGCCG	CASSYSHSYEQYF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	4	6	1	1	1	23	40	43	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSHSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCGAGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSARGTGNTEAFF	In	VDJ	1	33	2.3540825498280805E-4	3.594771241830065E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	1	6	0	23	35	-1	41	49														CASSARGTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGGGGACAGAGCTACGAGCAGTACTTCGGGCCG	CASRPGGQSYEQYF	In	VDJ	1	32	2.2827467149848054E-4	3.485838779956427E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	3	6	2	23	34	47	40	49														CASRPGGQSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCAAAGGGGGTTACACTGAAGCTTTCTTTGGACAA	CAISKGGYTEAFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	3	3	2	23	34	43	37	45														CAISKGGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGTCAGGGGAGGAAAACTGTTTTTTGGCAGT	CASSYSVRGGKLFF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	0	4	2	10	3	3	23	40	49	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSVRGGKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCGGGACAGCTTATGGCTACACCTTCGGTTCG	CASSSGTAYGYTF	In	VDJ	1	31	2.2114108801415304E-4	3.3769063180827885E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	4	2	23	34	45	38	47														CASSSGTAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTAAGTATCAGGGAGAAGTAGCACAAATACGCAGTATTTTGGCCCA	CASN*VSGRSSTNTQYF	Stop	VDJ	1	30	2.1400750452982552E-4		51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	4	3	7	9	13	23	33	47	42	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASN*VSGRSSTNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCAAGCACTCTCCACCGGGGAGCTGTTTTTTGGAGAA	CAIQALSTGELFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	3	10	4	7	3	23	30	40	37	43						01,02								CAIQALSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGACAGCCTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSYSGTAFTGELFF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	5	4	1	4	23	40	48	41	52														CASSYSGTAFTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCCAGGAAACACCATATATTTTGGAGAG	CASSPPGNTIYF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	6	4	4	0	23	35	-1	39	41														CASSPPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCGTTCCCCGGGGGGGCGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	1.8547317059251545E-4		37	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	0	6	6	3	23	28	42	34	45														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSSRTTGELFF	In	VDJ	1	26	1.8547317059251545E-4	2.8322440087145967E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	4	1	7	4	3	0	23	36	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRTTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGGTTAGCGGGCAGATACGCAGTATTTTGGCCCA	CASS*G*RADTQYF	Stop	VDJ	1	26	1.8547317059251545E-4		42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	4	4	4	0	23	37	-1	41	48						01,02								CASS*G*RADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGCTACTGAAGCTTTCTTTGGACAA	CASSYRATEAFF	In	VDJ	1	25	1.7833958710818793E-4	2.723311546840959E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	8	0	5	1	1	23	38	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRATEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTGTTAGCGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSSVSGGQETQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	2	4	0	23	36	-1	40	50														CASSSVSGGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGAGTGGGACTTACCTACGAGCAGTACTTCGGGCCG	CASSYGGVGLTYEQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	10	2	8	2	23	38	52	46	54						01,02								CASSYGGVGLTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCCAAATAGGGGGACCTAATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	1.712060036238604E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	1	9	6	23	34	49	43	55														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGACCGAGGTCAGGGGCGGCACGAGCAGTACTTCGGGCCG	CASTDRGQGRHEQYF	In	VDJ	1	24	1.712060036238604E-4	2.6143790849673205E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	2	5	11	4	23	33	50	44	54														CASTDRGQGRHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGTCTCCCTGCATCGGAAAGACCTATGGCTCGGTTCG		Out	VDJ	1	23	1.640724201395329E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	1	8	18	15	12	23	35	53	50	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCCTCCGACAGGGTTGTCCACTATGAAAAACTGTTTTTTGGCAGT	CASRSSDRVVHYEKLFF	In	VDJ	1	23	1.640724201395329E-4	2.505446623093682E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	6	7	9	23	34	48	41	57														CASRSSDRVVHYEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGCCGGGGGGAGTTCGGGGAGCAGTACTTCGGGCCG	CASSRGEFGEQYF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	7	1	8	23	34	42	35	50														CASSRGEFGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTATGAGTAGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	1.5693883665520537E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	3	2	7	4	13	0	23	37	-1	50	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGGGCTATGGCTACACCTTCGGTTCG	CASSSGGYGYTF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	4	0	0	23	-1	-1	36	43														CASSSGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCTCTTGGACAGTAAATTCACCCCTCCACTTTGGGAAC	CASSASWTVNSPLHF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	5	7	7	2	23	35	48	42	50														CASSASWTVNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCAGTGACAGGGCAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CVSSDRAGAYNEQFF	In	VDJ	1	21	1.4980525317087785E-4	2.2875816993464052E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	2	0	6	23	-1	42	35	48														CVSSDRAGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGACAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSLTGRNTEAFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	1	2	23	36	44	37	46														CASSLTGRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCAGGGGATGGCGGGGAGCTGTTTTTTGGAGAA	CASSDSGDGGELFF	In	VDJ	1	20	1.4267166968655033E-4	2.1786492374727668E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	7	0	4	23	-1	45	40	49														CASSDSGDGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGAAGGGTAGAGGAGCCGATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSGKGRGADSGANVLTF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	63	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	8	3	1	0	17	12	-1	34	29	51														CASSYSGKGRGADSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTGGCCCAGACAGGGACCCAAGAGACCCAGTACTTCGGGCCA	CAISVAQTGTQETQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	1	8	2	23	35	50	43	52														CAISVAQTGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTCAGGGTGGAACCTACGAGCAGTACTTCGGGCCG	CASSFQGGTYEQYF	In	VDJ	1	19	1.355380862022228E-4	2.0697167755991285E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	2	2	5	23	36	43	38	48														CASSFQGGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCAAGGGCCTAGGGGATACTGAAGCTTTCTTTGGACAA	CASSLKGLGDTEAFF	In	VDJ	11	761	0.0054286570315732405	0.008289760348583877	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	2	5	10	2	24	37	52	47	54													Vb 18	CASSLKGLGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
TATTTCTGTGCCAGCTCGCCCAAAAGGGCCGCGAGGGTGAACCAGGGGGGAAACAATGAGCAGTTCTTCGGGCCA	CASSPKRAARVNQGGNNEQFF	In	VDJ	3	244	0.0017405943701759143	0.0026579520697167756	63	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	1	5	25	3	6	17	49	42	52													Vb 18	CASSPKRAARVNQGGNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTCACCGGCCCCTACGAGCAGTACTTCGGGCCG	CASSFTGPYEQYF	In	VDJ	3	234	0.001669258535332639	0.0025490196078431374	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	5	9	0	2	6	1	24	36	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSFTGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTAGCCCAGGGGCTAATATGGTGGACATTCAGTACTTCGGCGCC	CASSPGANMVDIQYF	In	VDJ	3	232	0.001654991368363984	0.0025272331154684094	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	9	4	2	8	5	12	24	32	43	37	55													Vb 18	CASSPGANMVDIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTACGGGGACGGCGAAAGAGACCCAGTACTTCGGGCCA	CASSPTGTAKETQYF	In	VDJ	3	202	0.0014409838638341583	0.0022004357298474947	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	6	0	7	3	7	5	24	35	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTGTAKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATACAGGACAGGGACTCACCCCTCCACTTTGGGAAC	CASSIQDRDSPLHF	In	VDJ	3	201	0.001433850280349831	0.0021895424836601307	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	10	5	2	24	36	49	41	51													Vb 18	CASSIQDRDSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCTGCCGGGACAGGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSSAGTGIYNEQFF	In	VDJ	3	181	0.0012911786106632806	0.001971677559912854	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	3	6	2	24	36	51	42	53													Vb 18	CASSSAGTGIYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTGGACGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	163	0.0011627741079453854		44	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	1	7	1	3	2	24	38	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGGGATCAGCCCCAGCATTTTGGTGAT	CASSQGDQPQHF	In	VDJ	2	138	9.844345208371973E-4	0.0015032679738562092	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	1	5	0	0	24	-1	-1	37	43													Vb 18	CASSQGDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCGACAGCGACTACTGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTATTAYNEQFF	In	VDJ	2	128	9.130986859939221E-4	0.0013943355119825707	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	6	2	5	2	3	9	24	35	43	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTATTAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTGGACAGCGGGAGATACGCAGTATTTTGGCCCA	CASSWTAGDTQYF	In	VDJ	2	107	7.632934328230443E-4	0.0011655773420479302	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	6	1	5	5	2	4	24	35	43	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSWTAGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGGCCGCAGATACGCAGTATTTTGGCCCA	CASSPTAADTQYF	In	VDJ	1	99	7.062247649484242E-4	0.0010784313725490195	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	2	7	4	0	5	24	-1	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTAADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTCAGGGCCCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRSGPPSYNEQFF	In	VDJ	1	99	7.062247649484242E-4	0.0010784313725490195	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	3	0	3	5	24	40	48	43	53													Vb 18	CASSPRSGPPSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATACGGATCGGAGCCCCAGCATTTTGGTGAT	CASSYGSEPQHF	In	VDJ	1	95	6.776904310111142E-4	0.0010348583877995642	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	5	1	8	8	3	4	24	36	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSYGSEPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCACAGATCTAGGACTGAAGCTTTCTTTGGACAA	CASSPPHRSRTEAFF	In	VDJ	1	90	6.420225135894765E-4	9.80392156862745E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	3	5	5	2	7	24	41	47	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPHRSRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGACACTCCGAACACTAAAGCTTTCTTTGGACAA	CASSPDTPNTKAFF	In	VDJ	1	88	6.277553466208215E-4	9.586056644880174E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	9	0	12	24	-1	43	38	55													Vb 18	CASSPDTPNTKAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGACAGTATGGCTACACCTTCGGTTCG	CASSPRQYGYTF	In	VDJ	1	86	6.134881796521664E-4	9.368191721132897E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	5	2	0	24	38	-1	40	45													Vb 18	CASSPRQYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACCTACTCCTCTAACCTCGAGCAGTACTTCGGGCCG	CASSPGTYSSNLEQYF	In	VDJ	1	83	5.920874291991839E-4	9.041394335511983E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	0	7	6	0	15	24	-1	44	39	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGTYSSNLEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAACAGGGTGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPNRVNSGANVLTF	In	VDJ	1	82	5.849538457148564E-4	8.932461873638344E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	3	3	0	2	4	24	38	46	40	50													Vb 18	CASSPNRVNSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGGGTCTCGGTCAGCCCCAGCATTTTGGTGAT	CASSPAGLGQPQHF	In	VDJ	1	82	5.849538457148564E-4	8.932461873638344E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	4	6	0	6	24	-1	44	39	50						01,02							Vb 18	CASSPAGLGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACTGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSQLGGTEAFF	In	VDJ	1	81	5.778202622305289E-4	8.823529411764706E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	5	4	0	24	37	-1	41	48													Vb 18	CASSQLGGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGAACAGCGCATGAACACTGAAGCTTTCTTTGGACAA	CASSPPEQRMNTEAFF	In	VDJ	1	80	5.706866787462013E-4	8.714596949891067E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	3	5	0	3	4	24	41	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPEQRMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTTCGTCGGCAGGGGCAGATACGCAGTATTTTGGCCCA	CASSPPSSAGADTQYF	In	VDJ	1	78	5.564195117775463E-4	8.496732026143791E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	4	8	0	24	41	-1	49	55													Vb 18	CASSPPSSAGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGCGAAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSPREGSGNTIYF	In	VDJ	1	75	5.350187613245638E-4	8.169934640522876E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	5	3	1	6	0	24	38	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPREGSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGACGAGGGTACGGAACACTGAAGCTTTCTTTGGACAA	CASSPRTRVRNTEAFF	In	VDJ	1	73	5.207515943559087E-4	7.952069716775599E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	1	6	4	24	38	49	44	53													Vb 18	CASSPRTRVRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGCGACAGAAAACTATGGCTACACCTTCGGTTCG	CASSPATENYGYTF	In	VDJ	1	55	3.9234709163801345E-4	5.991285403050109E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	2	3	2	24	38	46	41	48													Vb 18	CASSPATENYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGGGGGGGCGAACACAGATACGCAGTATTTTGGCCCA	CASSPLGGANTDTQYF	In	VDJ	1	53	3.780799246693584E-4	5.773420479302832E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	0	2	1	5	24	40	48	41	53													Vb 18	CASSPLGGANTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGGGGGCGGGTTCGAGCAGTACTTCGGGCCG	CASSPTGGGFEQYF	In	VDJ	1	51	3.638127577007034E-4	5.555555555555556E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	6	0	5	24	-1	48	39	53													Vb 18	CASSPTGGGFEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGACACATATAACACTGAAGCTTTCTTTGGACAA	CASSLDTYNTEAFF	In	VDJ	1	43	3.067440898260832E-4	4.6840958605664487E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	2	2	5	24	36	43	38	48													Vb 18	CASSLDTYNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAAGGGACAGGGGACAAGAGACCCAGTATTTCGGGCCA		Out	VDJ	1	39	2.7820975588877314E-4		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			3	0	2	19	4	16	24	38	52	42	68								TCRBJ02-01,TCRBJ02-05					Vb 18	X+TCRBV18-01+TCRBJ02-X	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGACAGGGGAGGGCTATGGCTACACCTTCGGTTCG	CASSPQTGEGYGYTF	In	VDJ	1	38	2.710761724044456E-4	4.139433551198257E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	4	1	4	24	40	49	41	53													Vb 18	CASSPQTGEGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGGGAGGTGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	2.1400750452982552E-4		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	3	3	1	1	7	24	38	45	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCGGACAGGGGAAACTCACCCCTCCACTTTGGGAAC	CASSPADRGNSPLHF	In	VDJ	1	27	1.9260675407684297E-4	2.941176470588235E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	2	10	3	4	24	38	50	41	54													Vb 18	CASSPADRGNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAAGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPEGATNEKLFF	In	VDJ	1	22	1.5693883665520537E-4	2.3965141612200435E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	2	0	3	0	24	38	-1	41	46													Vb 18	CASSPEGATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCACACAGGGGGCCGCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	1.4980525317087785E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	3	4	3	24	37	50	41	53													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7678B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2207	1445	753	8	0	862	695	154	13	0	140182	91800	47835	547	0	0.199969307	7.55298519	0.28128165	7.00861359				151607	0.0127663305	0.188485846	0.218202055	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:51	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.6547349164542232	MSKCC- Snyder- P01-02		1935.0	
